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Summary 
In order to study the relationship between dioxin and PCB levels in feed and eggs, laying hens were 
fed with compound feed containing six different levels of dioxins, dioxin-like PCBs and indicator 
PCBs for a period of 56 days. This was followed by a period of another 56 days on clean feed. Dioxin 
levels varied from background to about three times the current tolerance limit of 0.75 ng TEQ/kg. At 
the higher dose levels a rapid increase was observed in the egg levels, followed by a more gradual 
increase. Steady state was not yet obtained after 56 days of exposure. Exposure to a feed containing 
2.0 ng TEQ/kg resulted in a rapid increase in the levels in eggs with a maximum of 20 pg TEQ/g fat, 
which decreased to levels around 7 pg TEQ/g after 56 days on clean feed. Exposure to feed at 1.0 ng 
TEQ/kg resulted in egg levels above the EU-limit of 3 pg TEQ/g fat within 10 days, with a maximum 
level around 9 pg TEQ/g after 56 days. The feed containing 0.4 ng TEQ/kg resulted in egg levels just 
above the limit. There was a clear linear relationship between the dioxin levels in eggs and feed.  
 Dioxin-like and indicator PCBs followed a very similar pattern as dioxins. Exposure to the 
highest indicator PCB level of 32 µg/kg feed resulted in egg levels of 300 ng/g fat. 
 Most dioxin congeners showed a very similar carry-over rate with the exception of the hepta and 
especially the octa congeners, where the carry-over was low. Dioxin-like PCBs showed a similar or 
even better carry-over as the lower chlorinated dioxins. Most of the indicator PCBs showed a similar 
good carry-over with the exception of PCBs 52 and 101. 
 Exposure through contaminated soil, mixed at 10% into feed, resulted in similar carry-over as 
feed. A number of different so-called binders, mixed at 0.5% into the feed, had no effect on the carry-
over of  dioxins and PCBs from the feed to the egg. 
 Data were successfully modelled in order to predict the levels after different exposure scenario’s. 
Overall, these data show that exposure to dioxins and dioxin-like PCBs rapidly results in increased 
levels in eggs and that the current EU limit for feed cannot guarantee egg levels below the EU-limit. 
Therefore, dioxin levels in chicken feed should be as low as possible and the current limit for dioxins 
in feed should be further reduced, at least in the case of chicken feeds. More in general, it is important 
to further harmonize the tolerance limits for feed and edible products like meat, eggs and milk. 
Information about the carry-over of contaminants in farm animals is essential for this purpose. 
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Samenvatting 
Om het verband te bestuderen tussen dioxine- en PCB-gehaltes in voer van kippen en hun eieren, 
werden 6 groepen legkippen gedurende 56 dagen gevoerd met voeders met verschillende gehaltes aan 
dioxines, dioxine-achtige PCBs en indicator PCBs. Vervolgens kregen de kippen gedurende 56 dagen 
schoon voer. Dioxinegehaltes in het voer varieerden tussen een laag achtergrondniveau en bijna drie 
keer de huidige dioxinenorm van 0,75 ng TEQ/kg. Bij de hogere doseringen werd een snelle toename 
in de dioxinegehaltes in eieren waargenomen, gevolgd door een periode met een meer geleidelijke 
toename. Steady-state condities werden echter niet bereikt binnen de proefperiode van 56 dagen. 
Blootstelling aan een voer met 2 ng TEQ/kg resulteerde in eieren met een maximum gehalte van 20 pg 
TEQ/g vet, hetgeen daarna weer afnam in de periode op schoon voer naar gehaltes rond 7 pg TEQ/g 
vet. Zo resulteerde blootstelling aan voer van 1 ng TEQ/kg, dus iets boven de norm, binnen 10 dagen 
in gehaltes boven de dioxine-norm voor eieren van 3 pg TEQ/g vet. Het hoogste gehalte in deze groep 
was 9 pg TEQ/g vet. Zelfs het voer van 0,4 ng TEQ/kg resulteerde uiteindelijk in eieren met dioxine-
gehaltes boven de norm. Er was een lineair verband tussen de gehaltes in voer en eieren. 
 Het verloop in de gehaltes van dioxine-achtige en indicator-PCBs in de eieren was vergelijkbaar 
met dat van de dioxines. Het hoogste indicator-PCB gehalte van 32 µg/kg voer resulteerde in een 
gehalte in eieren van 300 ng/g vet. 
 De meeste dioxine-congeneren vertoonden een vergelijkbare overdracht van voer naar ei, met 
uitzondering van de hepta en vooral de octa-congeneren, die een lage carry-over lieten zien. De 
dioxine-achtige PCBs toonden een vergelijkbare hoge overdracht als dioxines, evenals de meeste 
indicator-PCBs, met uitzondering van PCBs 52 en 101. 
 Blootstelling aan verontreinigde grond, gemengd door het voer (10%), leidde tot een vergelijkbare 
goede overdracht als bij de voeders. Toevoeging van een aantal zogenaamde binders aan verontreinigd 
voer leidde niet tot een lagere overdracht van dioxines en PCBs. 
 Op basis van de data en fysiologische gegevens over legkippen, werd een PB-PK model gemaakt, 
waarmee de gevolgen van een dioxinebesmetting via voer of grond voor de gehaltes in eieren op basis 
van blootstellingniveau en tijdsduur kunnen worden voorspeld.  
 De huidige studie laat zien dat verhoogde blootstelling van legkippen aan dioxines en PCBs leidt 
tot een snelle toename van de gehaltes in eieren. De huidige EU-normen voor dioxines in voer kunnen 
niet garanderen dat de gehaltes in eieren beneden de norm blijven. Derhalve moet er gestreefd worden 
naar zo laag mogelijke gehaltes van dioxines in voeders en zouden de huidige limieten voor dioxines 
in voeders, in elk geval voor kippen, verlaagd moeten worden. Het is daarnaast van groot belang om te 
streven naar een betere afstemming van dergelijke normen in voer en eindproduct, waarbij informatie 
over overdracht van contaminanten bij landbouwhuisdieren van essentieel belang is. 
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1  INTRODUCTION 
1.1 Properties of dioxins and PCBs 
Incidents with PCBs and dioxins (Figure 1) have shown that these compounds pose a major threat to 
edible products derived from food producing animals. Dioxins are produced as by-products in the 
synthesis of certain chemicals, like pentachlorophenol and 2,4,5-trichlorophenoxyacetic acid, and 
during incineration of waste. These compounds bind to the so-called Ah-receptor present in 
mammalian cells, thus resulting in the transcription of a large number of genes. In laboratory animals 
exposure results in tumours in the liver, and at even lower levels in effects on the immune and 
reproductive systems, as well as impaired learning. Based on these studies the World Health 
Organisation (WHO) and Scientific Committee on Food (SCF) have set very low exposure limits of 
respectively 1-4 pg TEQ/kg bw/day (WHO 2000) and 14 pg TEQ/kg bw/week (SCF 2001). These 
limits include the 17 toxic dioxins as well as 12 so-called planar PCBs which have similar properties 
to dioxins. Several studies have subsequently shown that at present, the exposure of part of the 
populations in Western countries exceeds these limits. Therefore, the EU has developed a strategy for 
further reducing the exposure. This includes the establishment of residue limits for food products, 
being 1 pg TEQ/g fat for pork, 2 pg TEQ/g fat for poultry, and 3 pg TEQ/g fat for beef, milk and eggs 
(EC 2001). In addition limits have been set for feed (0.75 ng TEQ/kg) and feed ingredients (0.75-6 
ng/kg TEQ) (EC 2002). TEQ (Toxic Equivalents) refers to the use of the so-called TEQ principle 
based on the fact that the concentrations of the different congeners are multiplied by a Toxic 
Equivalency Factor (TEF), expressing their relative toxicity to the most toxic congener 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD) (Berg et al 1998).  
 
 
 
 
 
Figure 1. Structures of dibenzo-p-dioxins 
(PCDDs), dibenzofurans (PCDFs) and 
polychlorobifenyls (PCBs). 
 
 
 
 
 
 
 
PCBs are a group of 209 different congeners, which have been produced as technical mixtures (like 
Arochlor 1254) and have been used in large amounts as e.g. heat transfer fluids, hydraulic lubricants 
and dielectric fluids for capacitors and transformers. Twelve of these congeners have a planar structure 
and have similar properties to dioxins. At this stage planar dioxin-like PCBs are included in the 
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exposure limits of WHO and SCF but not yet in the EU food and feed limits. Based on more detailed 
information on current levels of these PCBs, the EU limits will be adapted in the near future. Other 
non-dioxin-like PCBs have been shown to affect brain development (Schmidt 1999) and appear to be 
responsible for the tumour promotion effects of these mixtures (Plas et al 2001). In addition 
metabolites of non-dioxin-like PCBs interfere with the homeostasis of vitamin A and thyroid 
hormones (Safe 1994). In practice, the consumer will be exposed to a mixture of both dioxins, dioxin-
like PCBs and other PCBs and the toxicology of these mixtures is even more complex. As a result, no 
exposure limits for non-dioxin-like PCBs have been established thus far, contrary to limits for PCBs in 
food. In order to avoid difficulties in analysing all 209 congeners, it is customary to analyse only seven 
so-called indicator PCBs that represent the different technical mixtures. These include PCBs 28, 53, 
101, 138, 153 and 180 but also PCB 118, which is a dioxin-like mono-ortho PCB. 
1.2 Dioxins in eggs from organic farms in the Netherlands 
Since the dioxin crisis in 1999 in feed and food in Belgium, RIKILT has been involved in a number of 
monitoring programmes aiming at the early detection of contaminated feed and food ingredients and 
the discovery of possible new sources of dioxins. In one of these programmes, at least 400 animal 
feeds and feed ingredients are screened annually with the CALUX-bioassay to select possibly positive 
samples. Suspected samples are further investigated by GC/MS, as well as 5-10% of the negative 
samples. In general samples showing a positive response are fish oil and fish meal, and clay minerals. 
In 2001 a new programme was started, aiming at investigating products of animal origin, like meat and 
eggs. Over 300 samples, primarily originating from the National Plan for controlling products of 
animal origin, were screened in the CALUX-assay and suspected samples were further investigated by 
GC/MS. This part of the programme resulted in an estimation of the fraction of samples non-compliant 
with the legal limits. In addition samples collected in each quarter of the year were pooled per type of 
sample and analysed by GC/MS, in order to assess the average background level of dioxins and co-
planar PCBs in these products. Results are presented on the Internet site: www.rikilt.wur.nl/dioxinen. 
The approach was continued in 2002. 
 In 2001 this strategy resulted in the discovery that an egg obtained from a farm with free-range 
hens, contained dioxin levels above the then existing Dutch limit of 5 pg TEQ/g fat (Traag et al. 2002). 
The initial observation was followed by a focussed action on these types of eggs and showed a clear 
elevation in dioxin levels from free-range hens, in particular in eggs from farms producing eggs 
according to organic standards. The Dutch Food Inspection Service (KvW) pursued on these 
observations by sampling eggs from most of the organic farms in the Netherlands during the fall of 
2001. A total number of 68 egg samples were screened with the CALUX bioassay and 9 suspected 
samples were found. Further investigation by GC/MS resulted in six samples that exceeded the current 
EU limit for eggs of 3 pg TEQ/g (since July 2003), and three that exceeded the existing limit at that 
time of 5 pg TEQ/g (De Vries, 2002). In addition some of the samples contained high levels of dioxin-
like non-ortho PCBs, with a highest total TEQ level of 15 pg TEQ/g fat. 
 Follow-up studies were performed during the wintertime at the first farm, and these strongly 
suggested that the source of the contamination was not the feed, but the outdoor environment. Dioxin 
levels decreased when hens were kept inside, although not to the levels normally observed in eggs 
from hens kept in batteries. 
 In July 2003, new EU limits for dioxins in food and feed became official, including limits for 
eggs and feed, being respectively 3 pg TEQ/g fat and 0.75 ng TEQ/kg feed. However, eggs from free-
ranging hens were excluded from these limits until 1-1-2004. At the same time, studies were started to 
investigate the carry-over rates of dioxins and PCBs from feed and soil to eggs at relatively low levels, 
RIKILT rapport 2004.016 7
and to investigate possible ways for lowering the exposure and carry-over rates. In the autumn of 2003 
ASG, in cooperation with RIKILT, performed a study (Brandsma et al. 2004). A large number of farms 
with organic eggs were visited and investigated for possible sources of dioxins and factors that may 
contribute to the exposure of chickens to dioxins. This study shows that most eggs would comply with 
the current limit of 3 pg TEQ/g fat, but that 13% of the eggs, coming from 26% of the farms would not 
be able to meet this limit. 
 This report describes the results, being the relationship between dioxin and PCB levels in feed 
and eggs, and the effects of contaminated soil and of binders on the carry-over. A possible problem is 
that the experimentally determined carry-over as such cannot be extrapolated beyond the applied 
experimental protocol. This feature hampers the application of the experimental findings to all kinds of 
situations, which may be encountered in practical situations such as an accidental high-peak exposure. 
This limitation may be overcome by combining an experimental approach with mechanistically based 
mathematical modelling. In this case the kinetics, i.e. the combined process of uptake, distribution and 
elimination resulting in the accumulation of dioxins in eggs of the laying hen, are described in terms of 
a mathematical model, with model parameters estimated on the basis of the aforementioned 
experimental results. The results of the studies were used to develop such a mathematical model based 
on the physiology of the laying hen, that can now be used for predicting the levels in eggs resulting 
from a certain feed contamination, and the effect of certain variables on this relationship. 
1.3 Data from other studies 
Chickens have been involved in some major feed incidents with dioxins and PCBs, leading to clear 
effects like decreased hatching of eggs and symptoms called chicken edema disease (reviewed by 
Hoogenboom, 2004a). With respect to the relatively low exposure and contamination levels, which are 
observed in the eggs of free-range chickens, a limited amount of information is available. In the early 
nineties German investigators observed elevated levels of dioxins in eggs from free-range chickens 
(EAE Technology, 1999). Two different studies showed ranges of 0.4-11.4 and 0.5-22.8 pg I-TEQ/g as 
compared to 0.6-2.3 and 0.2-6.0 for eggs from battery-housed chickens. Shuler et al. (1997) performed 
a field survey on chickens from five farms (A-E) in Switzerland. Soil samples, taken from a depth of 
0-10 cm were analysed and shown to contain 11 (A), 13 (B), 1.8 (C), 1.3 (D) and 1.4 (E) ng I-TEQ/kg 
dry weight. Corresponding levels in single eggs were respectively 3.1 and 6.1 (A), 19 and 12 (B), 4.6 
and 2.3 (C), 6.1 (D) and 3.5 (E) ng I-TEQ/kg fat. The relatively low levels in eggs from farm A were 
hypothesised to be due to the high density of chickens on this particular farm as compared to the other 
farms, resulting in the disappearance of soil organisms. More recent results from a Swiss monitoring 
study on samples collected in 1999 and 2000, confirm that eggs often contain elevated dioxin levels 
(average 2.9, maximum 13 pg TEQ/g fat), with 6 out of 18 eggs with levels higher than 3 pg TEQ/g fat 
(Schmid et al. 2002). According to the authors, part of the elevated levels might be explained by the 
use of contaminated kaolinic clay in feed. Harnly et al. (2000) described a more controlled study in a 
contaminated area close to a pentachlorophenol wood treatment facility in Oroville, California, USA. 
Soil concentrations of around 6 ng I-TEQ/kg (range 1.5-46) resulted in egg levels of 20-50 ng I-
TEQ/kg fat (range 0.8-140). The fraction of eggs exceeding 10 ng I-TEQ/kg was around 70-90%. 
Modelling of the data indicated that for confined hens, a soil level of 2.7 ng TEQ/kg was required to 
result in an egg level of 10 ng I-TEQ/kg fat. However, a soil level of only 0.4 ng TEQ/kg was required 
for hens that had a larger area to forage. Again, this suggests a role for worms and insects, since their 
presence is more likely at lower densities. Air et al. (2002) reported dioxin levels around 15 pg TEQ/g 
fat (range 1-56) in eggs from hens reared on allotments in Newcastle upon Tyne. The contamination 
resulted from the use of incinerator ash for footpaths. Twenty months after removal of the ash, levels 
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decreased to an average of 19 pg TEQ/g (range 2-26) in eggs from chickens that were already 
contaminated. Levels in eggs from chickens newly introduced to the allotments were on average 8 pg 
TEQ/g (range 0-31). The pattern in the contaminated eggs indicated that the complete removal of the 
ash was not achieved. Rose et al. (2003), in studying the possible effects of the FMD animal pyres, 
observed in a small number of farms dioxin levels in eggs up to 7 pg TEQ/g (range 1-7) with total 
TEQ levels up to 34 pg TEQ/g (range 1-34). The eggs were not produced for commercial activities. 
The authors concluded that the pyres did not contribute to the contamination, also based on 
comparison with previous data showing similar levels in eggs sampled between 1994 and 1996 (FSA 
2000). Average levels in hen eggs were 6.3 pg TEQ/g fat (range 1-22). Recently the Food Standards 
Agency of Ireland (FSAI, 2004) investigated dioxins and PCBs in battery, free-range, barn and organic 
eggs. Average dioxin levels were respectively 0.29, 0.32, 0.27 and 1.43 pg TEQ/g fat, average total 
TEQ levels respectively 0.65, 0.79, 0.57 and 2.73 pg TEQ/g fat. Only four samples were analysed for 
the organic eggs, but one showed a dioxin level above the EU-limit of 3, with a total TEQ level of 6.6 
pg TEQ/g. These data clearly demonstrate that the problem is more widespread and that even higher 
levels might be expected at contaminated sites. 
Only few studies are available on the possible role of worms in the carry-over of dioxins and 
PCBs. Wågman et al (2001) showed that worms fed contaminated food are able to accumulate in 
particular the more chlorinated PCBs, mainly due to a slower elimination of these congeners. 
Matscheko et al (2002) studies levels in soil and worms and observed that the accumulation of certain 
PCBs from soil to worms is higher than that of 2,3,7,8-substituted dioxins. In general the ratio’s 
between worm lipids and soil organic matter were in the order of 1 to 20 for PCBs and 0.1 to 1 for 
dioxins, with higher accumulation of the tetra and penta chlorinated PCDD/Fs. Regarding the lipid 
content of worms (1-2%) and percentage of organic matter in soil (2-6%), levels of PCBs in worms on 
a wet weight base in general exceeded those in soil. For dioxins this seems to be less the case.  
In general these studies confirm that very low soil levels already may result in high levels in eggs, 
which appear to be a very sensitive product. 
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2 MATERIALS AND METHODS 
2.1 Preparation of feed 
2.1.1 Preparation of feed for Study A 
Feed was prepared with soy oil spiked with the different dioxin and PCB congeners. A blanc oil, 
obtained from Nutreco (Boxmeer, The Netherlands) was analysed by both CALUX and by GC/MS 
and shown to be low in dioxin-like compounds. Subsequently, a stock oil was prepared with about 
7500 pg TEQ/g of dioxins and dioxin-like PCBs. An aliquot of 200-gram oil was mixed with the 
following PCB stock solutions: 
• 7.5 ml PCB 105 100 ng/ml 
• 15 ml PCB 118 100 ng/ml 
• 1.2 ml PCB 156 100 ng/ml 
• 7.5 ml PCB 28 100 ng/ml 
• 15 ml PCB 52 100 ng/ml 
• 30 ml PCB 101 100 ng/ml 
• 30 ml PCB 138 100 ng/ml 
• 30 ml PCB 153 100 ng/ml 
• 15 ml PCB 180 100 ng/ml 
 
The organic solvent (nonane) was removed under vacuum. Subsequently the following standard 
mixtures were added: 
• 44 µl CIL EDF-4096 dioxins (tetra’s 2.5 ng/µl, penta’s, hexa’s and hepta’s 6.25 ng/µl and 
octa’s 12.5 ng/µl) 
• 408 µl CIL EC-4986 non-ortho PCBs (10 µg/ml) 
• 785 µl CIL EC-4987 mono-ortho PCBs (10 µg/ml) 
 
The organic solvent was again removed under vacuum (1 hr, 63ºC). The 200 ml oil was first diluted to 
1500 ml, and subsequently diluted for incorporation into the different feeds, as follows: 
• 30 gram + 1470 gram blank oil (oil b used for feed B) 
• 60 gram + 1440 gram blank oil (oil c used for feed C) 
• 265 gram + 3237 gram blank oil (oil d used for feed D) 
• 685 gram + 3882 gram blank oil (oil e used for feed E) 
• 420 gram + 980 gram blank oil (oil f used for feed F) 
 
Analysis of oil (b) by GC/MS showed a total TEQ content of 20 pg TEQ/g, with a contribution of 11 
pg TEQ/g for dioxins, 5.3 pg TEQ/g for non-ortho PCBs and 3.7 pg TEQ/g for mono-ortho PCBs. The 
blank oil contained a total TEQ content of 0.4 pg TEQ/g fat (upperbound). Based on these results the 
Nutreco feed mill in Heyen, The Netherlands, prepared the feeds with 0.95% of oils (b) to (f), and the 
blank oil a in the following quantities: 290 and 650 kg blank feed (prepared in 2 batches), 110 kg of 
feeds B, C, D and F, and 400 kg of feed E. 
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Table 1 shows the ingredients of the feed, Topline extra. 
 
Ingredient Amount (%) 
Corn 32.53 
Wheat  19.61 
Corn-byproducts   2.00 
Maizeglutenfeed 3.52 
Wheatglutenfeed 4.31 
Soyabeans, extracted  13.98 
Sunflower seed, extracted  7.42 
Rape seed extracted  2.33 
Limestone fine <15 mm  2.00 
Limestone 1-3 mm  7.55 
Monocalcium phosphate  0.06 
Sodiumchloride 0.16 
Sodiumcarbonate  0.12 
Chicken fat  4.00 
Methionin 98 0.09 
Fytase 5000 L  0.01 
Cholinchloride  0.02 
Fish oil 0.10 
Vitamin mix 44  0.30 
Total 100.00 
2.1.2 Preparation of feed for Study B 
Aim of this study was to assess the bioavailability of dioxins from contaminated soil. Therefore, feeds 
were prepared by mixing the blank feed with 10% of soil collected from two chicken farms with 
elevated dioxin and PCB levels in eggs. The soils were analysed and shown to contain dioxin levels of 
1.94 ng TEQ/kg (soil A) and 5.88 ng TEQ/kg (soil B). Pooled egg samples collected at the same time 
at these farms were shown to contain dioxin levels of 1.0 and 7.3 pg TEQ/g fat. As a control an 
additional feed was prepared by mixing feed E with 10% of clean sand. 
2.1.3 Preparation of feed for Study C 
Aim of this study was to assess whether or not binders would influence the bioavailability of dioxins 
and PCBs in feed. For this study a number of different binders were obtained from the producers. 
These materials were claimed to prevent the absorption of mycotoxins and as such might be potential 
candidates for reducing the absorption of dioxins as well. The materials were first screened by 
CALUX and analysed by GC/MS, and shown not to contain dioxins and PCBs above the limits. The 
following feeds were prepared: 
• feed E mixed with 0.5% Exal H 
• feed E mixed with 0.5% MycoAd A-Z 
• feed E mixed with 0.5% Klinofeed 
• feed E mixed with 0.5% Humac 
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2.2 Animal studies 
2.2.1 Study A 
Hens (Bovans Gold line, age about 45 weeks at the start) were housed in a three-tier battery with 3-4 
hens per cage. The different groups contained 12, 12, 12, 13, 26 and 13 animals respectively. After an 
adaptation period on blank feed for 1 week, hens were fed with the different feeds A to F for 56 days, 
followed by another 56 days on blank feed A. During the whole 112-day period eggs were collected 
and pooled per day per feeding group. On days 56 and 112, at least five hens from each group were 
slaughtered and abdominal fat, livers and the ovaries collected. The group fed with feed E was larger 
allowing the collection of tissues of another five animals on days 10 and 28.  
2.2.2 Study B and C 
Hens (ISA Brown Warren, age about 25 weeks at the start) were housed in a three-tier battery with 2-3 
hens per cage. The seven groups of 5 animals followed an adaptation period of one week on clean 
feed, and then were fed with the different feeds for 32 days. During the whole 32-day period eggs 
were collected and pooled per day per feeding group. On day 32 the hens from each group were 
slaughtered and abdominal fat, livers and the ovaries collected. 
2.3 Analysis of dioxins and dioxin-like PCBs 
Levels of dioxins, non-ortho and mono-ortho PCBs were determined by high resolution GC/MS, 
basically as described by Tuinstra et al. (1994). Eggs and ovaries were freeze dried and subsequently fat 
was extracted using Accelerated Solvent Extraction (ASE). Abdominal fat was melted in an oven at 70 
°C  After extraction or sample pretreatment 13C labelled dioxins and dioxin-like PCBs were added to the 
fat phase of the samples. Feed samples were extracted with ethylacetate or,  when minerals or soil was 
added to the feed (study B and C), with toluene using ASE. Prior to extraction13C labeled dioxins and 
dioxin-like PCBs were added to the  feed samples 
Separation between dioxins and fat was carried out using gel permeation chromatography. The 
system consisted of an HPLC pump (Gilson, model 305, an autosampler (Gilson, model 231) equipped to 
inject 12,5 ml of sample solution, and a fraction collector (Gilson, model 202) adapted to collect 300 ml 
fractions using 500 ml glass collection flasks. The glass GPC column (Spectrum) (60 x 2.5 cm) was 
packed with Biobeads SX 3. After an additional clean up with activated Al2O3, separation between planar 
compounds (dioxins and non-ortho PCBs) and non-planar compounds like other PCBs was carried out 
with porous graphitised carbon. The alumina (basic) clean-up was performed with an automatic sample 
preparation system using solid phase extraction columns (ASPEC, Gilson). The columns were packed 
with 1 gram deactivated alumina (7% water) shortly before use. Porous graphitised carbon clean up was 
performed using a HPLC system consisting of an HPLC pump (Gilson model 205), a column switching 
device (Gilson, valvemate), a solvent switching device (Gilson, valvemate), an autosampler (Gilson 
model 231), equipped with a 5 ml loop and a fraction collector (Gilson model 202) adapted to collect 100 
ml fractions. The column used was Hypercarb (100 X 4.6 mm) (Shandon). The final extract with planar 
compounds was concentrated to 10 µl and the extract containing the non-planar PCBs to 200 µl. Both 
extracts were analysed with gas chromato-graphy-high-resolution-mass spectrometry (HRGC-MS) 
(Autospec, Micromass). The mass spectrometric method to determine the tetra through octa dioxins is 
based on United States Environmental Protection Agency protocols. Included in the analysis is a standard 
QA programme e.g. determination of recovery of internal standards, accuracy of spiked samples and 
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blanks. Absolute levels were transfered to TEQ levels using the TEF values described by van den Berg 
et al. (1998).  
2.4 Analysis of indicator PCBs 
The seven indicator PCBs (28, 52, 101, 118, 138, 153 and 180) were analysed by GC/MS following 
on-line clean-up over a silica HPLC column using a large volume injector (LVI). In short, 200 mg of 
the homogenised fat sample is mixed with 800 µl of the internal standard solution of 13C PCB 118 and 
PCB 198 (6.25 ng/ml). Subsequently, 50 µl is injected onto the silica column and after elution of the 
fat with hexane, the direction of the flow is switched to back-flush and the column is cleaned with 3 
ml dichloromethane. The PCB containing fraction (approximately 1 ml) is directly transferred to the 
gas chromatograph, which is provided with an LVI. In the LVI the large amount of solvent was 
separated from the compounds of interest by an uncoated retention gap of 10 meters, which ends up in 
a retaining column of 1-meter coated with a non-polar phase. The temperature of the LVI, located in 
the oven of the GC, is slightly (80°C) above the boiling point of the mobile phase. Hexane is 
evaporated slowly and blown off via the Solvent Vapour Exit (SVE) while the PCB’s are retained on 
the 1-meter retaining column. After a specific time the majority of the solvent was evaporated, the 
SVE closed and the temperature of the oven was raised in order to start chromatography.  Detection 
was done by mass-spectrometry with a bench top system in Selected Ion Mode (SIM). 
2.5 CALUX analysis 
An aliquot of 0.5 g fat was mixed with hexane and extracted on acid silica as described previously. In 
each test series a blanc butter fat sample and butter fat samples containing 1, 2, 3 and 6 pg TEQ/g fat 
were included. The response obtained with the butter fat sample of 3 pg TEQ/g, containing 1.5 pg 
TEQ/g dioxins and 1.5 pg TEQ/g non-ortho PCBs, was used as the reference signal. Samples showing 
a lower response were declared negative, samples showing a higher response suspected.  
Aliquots of 5 gram feed or binder were mixed with 15 ml methanol/water 85/15 (v/v) and 
extracted twice with 20 ml hexane/diethyl ether 97/3 (v/v). The extract was reduced to 5 ml and 
purified over acid silica columns as described above. Feed samples were included as control samples. 
2.6 Mathematic modelling 
The transfer of total dioxin Toxic EQuivalents (TEQs) in laying hens, based on the physiology of 
laying hens and the physicochemical properties of dioxin-like substances was quantified by means of 
mathematical modelling. The mathematical model herein, which is described in detail in the 
accompanying Technical Information, was calibrated on the basis of the experimental results (time-
course of the TEQ in eggs and abdominal fat at 6 different contamination levels) mentioned above.  
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3 RESULTS 
3.1 Experimental 
3.1.1 Study A 
3.1.1.1. Dioxin and PCBs in feeds 
Appendix 1 shows the levels of the individual dioxins and dioxin-like PCBs in the various feeds, 
appendix 2 the levels of indicator PCBs. Each feed was analysed 3 to 5 times, corresponding to the 
number of samples taken from the different bags. The low standard deviation and variation coefficient 
demonstrates the good homogeneity of the feeds. Table 2 shows the intended and analysed dioxin, 
PCB and total TEQ levels. The relative contribution of dioxins, non-ortho and mono-PCBs was as 
intended, being respectively 50, 30 en 20%. However, the overall levels were in general higher than 
intended, which cannot be explained by the background levels in the feed ingredients. Since a rather 
broad range of different concentrations in feed was used, this deviation had no consequences for the 
aim of the study. Indicator PCB levels were respectively 0.2, 2.3, 4.3, 6.0, 14.2 and 31.7 µg/kg feed.  
 
Table 2. Intended and analysed levels of dioxins, non-ortho and mono-ortho PCB levels in the 
different feeds, expressed in ng TEQ/kg. 
 
Feed Dioxins no-PCBs mo-PCBs Total 
 Intended Analysed Intended Analysed Intended Analysed Intended Analysed 
         
A 0 0.04 0 0.00 0 0.00 0 0.04 
B 0.10 0.20 0.06 0.09 0.04 0.06 0.20 0.34 
C 0.20 0.30 0.12 0.17 0.08 0.11 0.40 0.58 
D 0.38 0.40 0.23 0.22 0.15 0.14 0.75 0.76 
E 0.75 0.97 0.45 0.55 0.30 0.33 1.50 1.85 
F 1.50 2.04 0.90 1.19 0.60 0.72 3.00 3.95 
3.1.1.2. Levels in eggs 
Table 3 shows the average feed consumption and the productivity of the hens, both during and after 
the exposure period. There was no effect of the exposure on these parameters. The exposure did not 
affect the average egg weight, but in all groups a slight decrease was observed after 3.5 weeks on 
clean feed, resulting in weights around 48-51 grams per egg. At present there is no explanation for this 
decrease, or possible consequences for the residue levels in the eggs.  
Appendix 3 (A-G) presents the levels of dioxins and PCBs in eggs and tissues, Figure 2 the levels 
of dioxins (A), non-ortho PCBs (B), mono-ortho PCBs (C) and total TEQ (D) in eggs. These data 
show that even after 8 weeks on contaminated feed, levels in eggs continued to increase. After 
cessation of the exposure, there was initially a small increase in the residues, and than a rapid decline, 
which was followed by a slower decrease. A similar profile was observed previously in a study with 
much higher dioxin and PCB levels (Hoogenboom et al. 2002). The formation of a full-grown yolk 
requires about ten days, meaning that eggs laid during the first days on clean feed were formed and 
contaminated still during the exposure period. Redistribution of dioxins from abdominal fat to the 
general circulation and thus to eggs, may explain the slow decrease in residues during the latter part of 
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the study. Figure 2A also shows that the current limit for eggs of 3 pg TEQ/g fat is rapidly exceded 
when exposed to feed containing dioxins at the current feed limit of 0.75 ng TEQ/kg.  
 
Table 3. Feed consumption and productivity of the hens during and after the exposure period 
 
 Exposure Clean feed 
Feed Feed 
consumption 
(g/day) 
Egg production 
(%) 
Egg weight* 
(g) 
Feed 
consumption 
(g/day) 
Egg production 
(%) 
Egg weight* 
(g) 
A 116 88 54 112 85 50 
B 108 82 56 111 86 51 
C 121 90 56 121 84 53 
D 113 80 55 110 86 52 
E 124 90 54 121 84 51 
F 108 90 54 111 79 51 
* average weight per egg without eggshell  
 
Appendix 4 (A-G) and Figure 3 show the levels of indicator PCBs in egg fat during the exposure and 
depletion period. In general the pattern was very similar to that of the dioxins and dioxin-like PCBs. 
The maximum level obtained at 56 days of exposure via the highest contaminated feed was around 
325 ng/g fat. Based on 4% fat in the feed, the feeds E and F would contain respectively 350 and 800 
ng/g fat, thereby exceeding the Belgium limit for feed of 200 ng/g. Only eggs from hens fed feed F 
actually exceeded the Belgium limit for indicator PCBs of 200 ng/g fat, although it cannot be excluded 
that after longer exposure also eggs from hens fed with feed E might approach the limit. 
Figure 4 shows the relationship between the dioxin levels in feed and eggs after different periods 
of exposure. There is a clear linear relationship between the feed levels and the levels in eggs at the 
different exposure times. This Figure also clearly demonstrates that even after a short period on feed 
contaminated at the current EU-limit of 0.75 ng TEQ/kg, the limit for eggs is exceeded.  
3.1.2 Study B 
Appendix 5 shows the levels of dioxins and PCBs in feed E, feed E mixed with 10% sand and the two 
blank feeds mixed with 10% of the soils sampled at two chicken farms. Appendix 6 and 7 show the 
dioxin and PCB levels in the eggs from the hens fed with these feeds, appendix 8 the dioxin and 
dioxin-like PCB levels in the abdominal fat. As shown in Figure 5, time-related levels in the eggs from 
the hens fed with feed E and E mixed with 10% sand were very similar to the results obtained in study 
A (Figure 5).  
The dilution of contaminated feed with sand did not clearly influence the levels observed in the 
eggs and abdominal fat. The results obtained with the blank feed mixed with 10% soil A or soil B 
reflected the differences in the soil and feed levels. In this case, a plateau level appeared to be reached 
within a short period of exposure. Maximum dioxin and total TEQ levels measured in eggs from hens 
exposed to soil A were 2.4 and 2.9 pg TEQ/g fat. In the case of soil B, highest levels of 1.2 and 1.6 pg 
TEQ/g were observed. Again, levels in abdominal fat were lower than those for egg fat. For 
comparison, levels determined in pooled egg samples from the farms where the soil was sampled were 
7.3 and 1.0 pg TEQ/g fat (Appendix 9).  
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Figure 2. Levels of dioxins (A), non-ortho PCBs (B), mono-ortho PCBs (C) and total TEQ (D) in egg fat from hens fed with feeds containing 0.04 (A, +), 0.34 
(B, ∆), 0.58 (C, ▲), 0.76 (D, ○), 1.85 (E, ◊) and 3.95 (F, ▼) ng TEQ/kg of dioxins and PCBs.  
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Figure 3. Levels of indicator PCBs in egg fat from hens fed with feeds containing 0.2 (A, +), 2.3 (B, 
∆), 4.3 (C, ▲), 6.0 (D, ○), 14.2 (E, ◊) and 31.7 (F, ▼) µg/kg feed of indicator PCBs. 
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Figure 4. Relation between dioxin levels in feed and egg fat after 10 (▼), 32 (▲) and 58 (●) days of 
feeding contaminated feed. Solid lines represent the current limits in feed and eggs, dashed lines the 
action limits in the EU. 
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Figure 5. Levels of dioxins (A) and total TEQ (B) in egg fat from hens fed with feed 750 (●), feed 750 
mixed with 10% sand (▲), and blank feed mixed with 10% soil A (♦) or soil B (?). For comparison 
the results obtained with feed 750 in the first study are included (○, open circle). 
 
3.1.3 Study C 
Appendix 10 shows the levels of dioxins and PCBs in the four feeds supplemented with the different 
binders. Appendix 11 and 12 show the dioxin and PCB levels in egg and abdominal fat of the hens fed 
with these feeds as compared to the feed E. These data show that the binder had little or no effect on 
the residue levels of dioxins and PCBs in the eggs 
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3.2 Mathematical modelling 
3.2.1 Study A 
The outcome of the calibration of the mathematical model is shown in Figure 6. As can be seen, the 
model could describe the accumulation of dioxins in hens and hen’s eggs quite well. The model 
indicates that the half-life time of dioxins in these laying hens is about 1.7 months or 7 weeks. This 
means that continuous administration of a certain dose level will result in steady state, i.e. constant 
concentration levels, after about 8 months. In non-laying hens the half-life was calculated to be 14 
months, indicating once again that excretion by egg yolk fat is the main route of elimination. In the 
range of the administered dose levels the model predicts a linear dose-response relation (dose levels in 
feed-concentration levels in eggs, see also Figure 3), i.e. the model predicts a constant transfer factor 
between the dose levels in feed and the resulting steady state levels in egg yolk fat, or: 
 “steady state concentration” in egg yolk fat = 17.6 x concentration in feed 
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Figure 6. Concentration in abdominal fat (upper panel) and egg yolk (lower panel). The lines show the 
calculated concentration-time curves, the symbols denote experimental data. Five contamination 
levels: 0.34 ng/kg feed (B, lower line, *), 0.58 ng/kg feed (C, next lower line, +), 0.76 ng/kg feed (D, 
middle line, x), 1.85 ng/kg feed (E, next upper line, *) and 3.95 ng/kg feed (F, upper line, +). 
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with the steady state concentrations in egg yolk fat and feed in respectively pg TEQ/g fat and ng 
TEQ/kg feed. Applying this equation to the experimentally used feed levels of 0.34, 0.58, 0.76, 1.85 
and 3.95 ng TEQ/kg feed leads to calculated steady state levels in eggs of 6, 10, 13, 33 and 70 pg 
TEQ/g fat. On the average these steady state levels are about two times higher than the levels observed 
after 56 days of exposure (3, 6, 7, 19 and 43 pg TEQ/g egg yolk fat). Similarly, a feed level of 0.76 ng 
TEQ/kg leads to a calculated steady state level of 13 pg TEQ/g egg yolk fat. This level clearly exceeds 
the current EU limit of 3 pg TEQ/g egg yolk fat. Further model calculation showed that, if steady state 
levels in egg yolk fat not exceeding 10, 5 or 3 pg TEQ/g fat are required, the corresponding 
contamination levels of feed should not exceed 0.57, 0.29 or 0.17 ng TEQ/kg feed. So, according to 
the model, when steady state levels of dioxins in egg yolk fat are not to exceed 3 pg TEQ/g fat the 
concentration should not exceed 0.17 ng TEQ/kg feed, being about 4 times lower than the current EU-
limit. 
The model also indicates that, contrary to current beliefs, abdominal fat and egg yolk fat display 
different dioxin kinetics during the period of contaminated feed administration. During the period of 
contaminated feed administration the concentration in egg yolk fat exceeds the levels in abdominal fat. 
However, soon after administration of clean feed, concentration levels in abdominal fat exceed those 
in egg yolk fat (see figure 7). 
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Figure 7. Concentration in egg yolk fat and abdominal fat. The lines show the calculated 
concentration-time curves, the symbols denote experimental data. Data: egg yolk fat (*) and 
abdominal fat (+). 
3.2.2 Study B 
The model, as calibrated under part A, readily predicted the accumulation of dioxins, furans and PCB’s 
from feed to which 10% contaminated soil had been added, assuming the absorption fraction to be 
60%  (in the case of soil from farm A) and 40% (in the case of soil from farm B; to be compared with 
an absorption fraction of near 100 % used in part A). The modelling also suggests that the apparent 
plateau levels observed for soil, are merely due to the short exposure period, and that maximum levels 
reached after several months of exposure might actually be two to three-fold higher.  
  Together with the experimental observations the mathematical analysis confirms observations 
published elsewhere (Stephens et al., 1990, 1994, 1995; Petreas et al., 1991; Schuler et al., 1997; 
Byrne and Ferrario, 2003) that the absorption of dioxins, furans and PCB’s from soil, and subsequent 
carry-over to the egg, by laying hens might be substantial.   
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Figure 8. Total TEQ levels in eggs from hens fed with clean feed mixed with 10% of contaminated 
soil. Two upper lines: contamination levels representing range from 0.53 to 0.64 ng TEQ/ kg feed 
(upper and lowerbound levels), absorption fraction 60%, data + (soil A). Two lower lines: 
contamination levels representing range from 0.37 to 0.54 ng TEQ/ kg feed, absorption fraction 40%, 
data * (soil B). 
3.2.3 Study C 
As already shown feed containing a nominal concentration of 1.85 ng TEQ/kg feed led to a rapid 
accumulation of dioxins, furans and PCBs in egg yolk fat. When binders were added to the feed in a 
concentration of 0.1-1%, the experimentally observed accumulation fell within the accumulation as 
expected from feed containing a concentration + 10% of the nominal value (see Figure 9; ± 10% was 
taken to represent the uncertainty in the nominal concentration). This result confirms that in these 
experiments none of the added binders showed any effectiveness in reducing the absorption of dioxins, 
furans or PCB’s from the hen’s gastro-intestinal tract.     
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Figure 9. Predicted total TEQ levels in eggs from hens fed with feed containing 1.85 ng TEQ/kg feed 
(calculated, line in middle, data *), plus 10% (calculated, upper line), minus 10% (calculated, lower 
line). Other data: feed + clean sand, feed + different “binders” (Exal H, MycoAd A-Z, Humac, 
Klinofeed).  
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3.3 Carry-over rates of individual congeners 
In order to compare the relative carry-over of individual congeners from feed to eggs, it is best to 
calculate the so-called Carry-over rate (COR), defined as the percentage of the amount of a certain 
congener excreted in the eggs, as compared to the amount ingested from the feed. Ideally, this should 
be done under steady-state conditions. Assuming a daily fat excretion of 5.1 g and daily feed intake of 
116 g, CORs were calculated for feeds E and F in study A (Appendix 13). These data suggest a COR 
for the more important lower chlorinated congeners around 40% and a lower COR for the higher 
chlorinated hepta and octa congeners. The non-ortho and mono-ortho PCBs showed similar CORs as 
the lower chlorinated dioxins although some mono-ortho PCB congeners appeared to have even higher 
CORs. These were present at relatively low concentrations and in practice do not contribute 
significantly to the TEQ levels. In the case of the indicator PCBs, the lower chlorinated PCBs 53 and 
101 showed very low carry-over rates, contrary to PCB 28. Similar has been observed previously in 
broilers (Hoogenboom et al. 2004).  
It is important to realize that after reaching steady-state, CORs are expected to be doubled, 
implying that the amounts excreted in the eggs will be close to the amounts ingested. Before steady 
state conditions are reached, part of the absorbed compounds are still accumulated in the body fat. As 
for total TEQ levels, the absorbed fraction ranges between about 90% and 100%, the COR for total 
TEQs at steady state would range between the same limits. 
 
4 CONCLUSIONS 
• Laying hens are sensitive indicators for dioxin contamination of feed and environment, 
meaning that relatively low exposure levels may result in high levels in the egg yolk. This is 
not only true for contaminated feed but also (to a lesser extent) for contaminated soil. 
      
• The new EU limit for feed of 0.75 ng TEQ/kg, established in 2002, is insufficient to guarantee 
that levels in eggs will not exceed the limit of 3 ng TEQ/kg fat. A further decrease in the feed 
limit by a factor 4 is required to achieve this goal. 
 
• There are currently no Dutch or European limits for indicator PCBs in feed or eggs. The 
Belgium limit of 200 ng/g fat for feed does ensure that the limit for eggs of 200 ng/g fat is not 
exceeded. 
 
• Addition of binders at the tested levels has no observable effect on the resulting residues of 
dioxins and PCBs in hens. 
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Appendix 1. Levels of dioxins, non-ortho and mono-ortho PCBs in the different feeds. Results are expressed as the mean of 3 to 5 analyses, with the standard 
deviation and the variation coefficient. Individual levels in  ng/kg. Total levels expressed in ng TEQ/kg. 
 
  Feed A   Feed B   Feed C   Feed D   Feed E   Feed F  
 mean SD %CV mean SD %CV mean SD %CV mean SD %CV mean SD %CV mean SD %CV 
Dioxins                   
2,3,7,8-TCDF 0.01 0.00 24 0.04 0.01 35 0.04 0.00 3 0.06 0.00 2 0.12 0.01 4 0.25 0.01 2 
1,2,3,7,8-PeCDF 0.02 0.01 41 0.06 0.01 11 0.10 0.00 4 0.14 0.01 4 0.33 0.00 1 0.66 0.02 2 
2,3,4,7,8-PeCDF 0.01 0.00 23 0.06 0.01 11 0.10 0.00 3 0.13 0.01 5 0.33 0.01 3 0.67 0.02 3 
1,2,3,4,7,8-HxCDF 0.01 0.00 24 0.06 0.00 7 0.11 0.00 1 0.15 0.00 2 0.34 0.01 3 0.70 0.01 1 
1,2,3,6,7,8-HxCDF 0.01 0.00 10 0.05 0.01 9 0.11 0.00 3 0.14 0.00 2 0.33 0.01 3 0.68 0.04 5 
2,3,4,6,7,8-HxCDF 0.01 0.00 12 0.06 0.01 11 0.14 0.02 16 0.15 0.03 17 0.43 0.02 5 0.84 0.14 16 
1,2,3,7,8,9-HxCDF <0.01   0.06 0.01 12 0.10 0.00 3 0.14 0.00 3 0.32 0.01 3 0.67 0.01 1 
1,2,3,4,6,7,8-HpCDF 0.02 0.01 22 0.08 0.01 6 0.14 0.01 4 0.18 0.01 3 0.40 0.01 2 0.82 0.02 2 
1,2,3,4,7,8,9-HpCDF 0.01 0.01 10 0.05 0.00 6 0.10 0.01 5 0.14 0.00 3 0.32 0.01 3 0.66 0.02 3 
OCDF 0.05 0.02 47 0.12 0.01 8 0.23 0.01 5 0.29 0.01 4 0.63 0.01 2 1.39 0.14 10 
2,3,7,8-TCDD <0.01   0.05 0.02 46 0.05 0.00 6 0.06 0.00 3 0.14 0.00 2 0.30 0.01 2 
1,2,3,7,8-PeCDD 0.01 0.00 13 0.07 0.01 9 0.11 0.00 4 0.16 0.00 2 0.37 0.00 1 0.79 0.01 1 
1,2,3,4,7,8-HxCDD 0.01 0.00 3 0.07 0.01 6 0.13 0.01 5 0.17 0.00 1 0.40 0.01 2 0.84 0.01 1 
1,2,3,6,7,8-HxCDD 0.01 0.00 9 0.06 0.00 7 0.12 0.00 3 0.15 0.00 3 0.35 0.01 4 0.74 0.01 1 
1,2,3,7,8,9-HxCDD 0.01 0.00 12 0.07 0.01 9 0.13 0.00 2 0.17 0.01 3 0.40 0.01 3 0.84 0.01 1 
1,2,3,4,6,7,8-HpCDD 0.06 0.02 28 0.11 0.01 5 0.18 0.01 3 0.22 0.01 4 0.42 0.01 3 0.84 0.02 2 
OCDD 0.58 0.16 28 0.74 0.22 30 0.84 0.04 5 0.92 0.07 7 1.34 0.05 4 2.57 0.63 24 
Total level  [ub] 0.04 0.00 10 0.20 0.04 18 0.30 0.01 2 0.40 0.01 2 0.97 0.01 1 2.04 0.03 2 
non-ortho-PCBs                   
PCB 81 0.04 10 22 0.84 0.04 5 1.61 0.03 2 2.17 0.03 1 5.12 0.14 3 10.86 0.17 2 
PCB 77 0.56 131 24 1.99 0.04 2 3.82 0.21 6 4.75 0.07 2 10.85 0.16 1 22.06 0.63 3 
PCB 126 0.03 5 17 0.77 0.03 4 1.50 0.04 3 2.01 0.04 2 4.98 0.10 2 10.86 0.13 1 
PCB 169 0.02 9 52 0.75 0.01 2 1.51 0.02 1 2.04 0.01 0 4.89 0.07 1 10.55 0.12 1 
Total level [ub] 0.00 0.00 16 0.09 0.00 4 0.17 0.00 3 0.22 0.00 2 0.55 10 2 1.19 0.01 1 
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Appendix 1 continued 
  Feed A   Feed B   Feed C   Feed D   Feed E   Feed F  
 mean SD %CV mean SD %CV mean SD %CV mean SD %CV mean SD %CV mean SD %CV 
mono-ortho PCBs                   
PCB 123 <1   2 1 54 2 0 4 2 0 2 5   14 1 10 
PCB 118 6 0 5 265 4 1 509 3 0 657 4 1 1576 15 1 3454 66 2 
PCB 114 <1   2 1 50 2 0 6 3 0 4 6   14 1 8 
PCB 105 2 0 5 147 3 2 287 3 1 372 2 1 894 14 2 1940 63 3 
PCB 167 <1   2 1 50 2 0 2 3 0 8 10 2 20 24 1 6 
PCB 156 1 0 11 24 1 4 45 1 1 59 1 1 139 2 1 307 10 3 
PCB 157 <1   3 1 36 4 0 2 5 0 6 13 1 8 26 2 9 
PCB 189 <1   2 1 37 3 0 2 4 0 2 10 0 3 21 1 4 
Total level [ub] 0.00 0.00 3 0.06 0.00 4 0.11 0.00 1 0.14 0.00 1 0.33 0.00 1 0.72 0.02 2 
                   
Sum [ub] 0.04 0.00 10 0.34 0.04 12 0.58 0.01 2 0.76 0.01 1 1.85 0.01 1 3.95 0.06 1 
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 Appendix 2. Levels of indicator PCBs in the various feeds. Results are expressed as the mean of 3 to 5 analyses, with the standard deviation and the variation 
coefficient. Levels expressed in µg/kg. 
 
  Feed A   Feed B   Feed C   Feed D   Feed E   Feed F  
 mean SD %CV mean SD %CV mean SD %CV mean SD %CV mean SD %CV mean SD %CV 
                   
PCB 28 0.02 0.02 80 0.20 0.03 13 0.33 0.02 7 0.44 0.03 7 0.98 0.01 1 2.13 0.02 1 
PCB 52 0.02 0.01 51 0.21 0.01 3 0.40 0.03 7 0.55 0.03 5 1.30 0.02 2 2.91 0.05 2 
PCB 101 0.03 0.00 11 0.45 0.02 4 0.84 0.07 8 1.20 0.04 3 2.88 0.09 3 6.33 0.18 3 
PCB 118 0.01 0.00 8 0.21 0.01 4 0.41 0.03 6 0.58 0.03 6 1.37 0.03 2 3.07 0.10 3 
PCB 138 0.04 0.01 11 0.48 0.02 3 0.91 0.07 7 1.28 0.05 4 2.99 0.07 2 6.72 0.29 4 
PCB 153 0.03 0.00 9 0.44 0.01 2 0.83 0.06 7 1.17 0.04 3 2.79 0.06 2 6.27 0.21 3 
PCB 180  <0.01     0.28 0.01 3 0.54 0.04 8 0.77 0.04 5 1.89 0.05 3 4.27 0.16 4 
                                   
Sum 0.16 0.02 14 2.27 0.03 1 4.25 0.30 7 5.98 0.24 4 14.20 0.30 2 31.70 0.93 3 
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Appendix 3A.. Levels of dioxins. non-ortho and mono-ortho PCBs in eggs, abdominal fat and ovaries from hens fed with blank feed A. Individual levels 
expressed in pg/g fat (dioxins, non-ortho PCBs) and ng/g fat (mono-ortho PCBs). Total levels expressed as pg TEQ/g fat. 
 
 Eggs  abdominal fat ovaries
Day 0 2 5 10 18 32 56 58 61 66 74 88 112 56 112 56 112
Dioxins         
2,3,7,8-TCDF < 0.50 < 0.50 < 0.50 * <0.25 * 0,20 0.14 * * <0.05 0.12 0.15 0.16 0.12 0.21 0.09
1,2,3,7,8-PeCDF 0.13 < 0.10 < 0.10 0,11 <0.10 * <0.10 <0.10 <0.10 <0.10 <0.10 <0.10 0,13 <0.10 <0.10 <0.10 <0.10
2,3,4,7,8-PeCDF 0.20 0.11 < 0.10 <0.10 <0.10 * 0.14 0.11 <0.10 <0.10 <0.10 0,10 0,12 <0.10 0,10 0,10 <0.10
1,2,3,4,7,8-HxCDF < 0.10 < 0.10 < 0.10 <0.10 <0.10 0.16 * <0.10 <0.10 <0.10 <0.10 0.25 0,14 <0.10 0,11 <0.10 <0.10
1,2,3,6,7,8-HxCDF < 0.10 < 0.10 < 0.10 <0.10 <0.10 0.13 <0.10 <0.10 <0.10 <0.10 <0.10 <0.10 <0.10 <0.10 <0.10 <0.10 <0.10
2,3,4,6,7,8-HxCDF < 0.10 < 0.10 < 0.10 <0.10 <0.10 * <0.10 <0.10 <0.10 <0.10 <0.10 <0.10 <0.10 <0.10 <0.10 <0.10 <0.10
1,2,3,7,8,9-HxCDF < 0.10 < 0.10 < 0.10 <0.10 <0.10 <0.10 <0.10 <0.10 <0.10 <0.10 <0.10 <0.10 <0.10 <0.10 <0.10 <0.10 <0.10
1,2,3,4,6,7,8-HpCDF 0.38 < 0.25 < 0.25 * * 0.25 <0.25 <0.25 <0.25 <0.25 <0.25 <0.25 0,37 <0.25 0,27 <0.25 <0.25
1,2,3,4,7,8,9-HpCDF < 0.25 < 0.25 < 0.25 <0.25 <0.25 <0.25 <0.25 <0.25 <0.25 <0.25 <0.25 <0.25 <0.25 <0.25 <0.25 <0.25 <0.25
OCDF 1.99 0.58 < 0.50 <0.50 <0.50 1.49 <0.50 0.52 <0.50 <0.50 <0.50 1.84 0.53 <0.50 <0.50 <0.50 <0.50
2.3.7.8-TCDD 0.11 < 0.05 < 0.05 <0.05 <0.05 0.13 <0.05 <0.05 <0.05 <0.05 <0.05 <0.05 0.05 0.08 <0.05 0.08 <0.05
1.2.3.7.8-PeCDD < 0.10 < 0.10 < 0.10 0.126 <0.10 0.15 0.15 <0.10 <0.10 <0.10 <0.10 <0.10 <0.10 <0.10 <0.10 <0.10 <0.10
1.2.3.4.7.8-HxCDD < 0.10 < 0.10 < 0.10 <0.10 <0.10 * <0.10 <0.10 <0.10 <0.10 <0.10 <0.10 <0.10 <0.10 <0.10 <0.10 <0.10
1.2.3.6.7.8-HxCDD 0.10 < 0.10 < 0.10 * <0.10 0.19 0.14 <0.10 <0.10 <0.10 <0.10 <0.10 <0.10 <0.10 <0.10 <0.10 <0.10
1.2.3.7.8.9-HxCDD < 0.10 < 0.10 < 0.10 <0.10 <0.10 0.12 <0.10 <0.10 <0.10 <0.10 <0.10 <0.10 <0.10 <0.10 <0.10 <0.10 <0.10
1.2.3.4.6.7.8-HpCDD 1.80 0.66 0.60 0.72 0.54 0.70 1.07 0.95 0.71 * 0.47 1.55 0.69 0.46 0.54 0.71 0.98
OCDD 71.1 12.5 4.87 5.67 4.21 7.76 12.2 12.4 7.02 5.08 4.00 18.0 8.77 3.77 4.71 5.86 20.01
Total level  [ub] 0.46 0.34 0.34 0.32 0.36 0.44 0.38 0.31 0.29 0.29 0.29 0.33 0.32 0.33 0.30 0.40 0.30
non-ortho PCBs         
PCB 81 1.24 0.97 1.17 1.8 1.44 3.38 2.93 1.57 1.55 0.90 0.67 1.03 1.29 1.79 1.13 1.43 0.83
PCB 77 13.4 15.6 17.1 18.3 29.2 24.9 25.3 22.4 20.1 11.5 15.3 13.2 16.4 24.36 15.53 18.68 11.81
PCB 126 2.36 2.05 1.85 2.55 2.17 3.48 2.75 1.85 1.63 1.59 1.35 1.5 1.34 2.35 1.39 1.91 1.10
PCB 169 0.42 0.28 0.36 * 0.36 * 0.78 0.35 * * 0.50 0.30 * 0.48 0.29 0.32 0.22
Total level [ub] 0.24 0.21 0.19 0.26 0.22 0.35 0.29 0.19 0.17 0.16 0.14 0.15 0.14 0.24 0.14 0.20 0.10
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 Eggs  abdominal fat ovaries
Day 0 2 5 10 18 32 56 58 61 66 74 88 112 56 112 56 112
mono-ortho PCBs         
PCB 123 < 0.01 < 0.01 < 0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01
PCB 118 0.38 0.36 0.35 0.43 0.41 0.42 0.28 0.30 0.27 0.26 0.25 0.28 0.25 0.39 0.28 0.35 0.47
PCB 114 < 0.01 < 0.01 < 0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01
PCB 105 0.10 0.10 0.09 0.11 0.11 0.12 0.08 0.09 0.07 0.06 0.06 0.08 0.07 0.10 0.07 0.09 0.17
PCB 167 0.02 0.02 0.02 * * * * * * * * * * * * * 0.02
PCB 156 0.06 0.06 0.06 0.07 0.06 0.06 0.05 0.05 0.05 0.05 0.04 0.04 0.04 0.07 0.05 0.05 0.04
PCB 157 0.01 < 0.01 < 0.01 0.01 * <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 0.01 <0.01 <0.01 <0.01
PCB 189 < 0.01 < 0.01 < 0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 * <0.01 <0.01
Total level [ub] 0.09 0.09 0.08 0.10 0.10 0.10 0.07 0.07 0.07 0.07 0.06 0.07 0.06 0.09 0.07 0.08 0.10
         
Sum [ub] 0.80 0.64 0.61 0.68 068 0.88 0.74 0.57 0.53 0.52 0.50 0.55 0.52 0.66 0.51 0.68 0.50
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Appendix 3B. Levels of dioxins. non-ortho and mono-ortho PCBs in eggs, abdominal fat and ovaries from hens fed with feed B. Individual levels expressed in 
pg/g fat (dioxins, non-ortho PCBs) and ng/g fat (mono-ortho PCBs). Total levels expressed as pg TEQ/g fat. 
 
 eggs abdominal fat ovaries
Day 0 2 5 10 18 32 56 58 61 66 74 88 112 56 112 56 112
Dioxins         
2,3,7,8-TCDF < 0.5 < 0.5 < 0.5 <0.25 <0.25 0.27 0.26 0.26 0.25 0.25 0.29 0.19 0.16 0.37 0.19 0.32 0.18
1,2,3,7,8-PeCDF < 0.10 < 0.10 * <0.10 0.32 0.37 0.53 * 0.38 0.39 * 0.33 0.29 0.50 0.28 * 0.21
2,3,4,7,8-PeCDF < 0.10 0.14 0.183 0.28 0.48 0.53 0.47 0.47 0.42 0.39 0.32 0.30 0.29 0.51 0.32 0.48 0.26
1,2,3,4,7,8-HxCDF < 0.10 < 0.10 0.183 0.49 0.42 0.55 0.59 0.47 0.47 0.24 0.21 0.28 0.22 0.34 0.24 0.50 0.13
1,2,3,6,7,8-HxCDF < 0.10 < 0.10 0.161 * 0.37 0.43 0.47 0.43 * 0.21 * * 0.13 0.26 0.18 0.46 0.11
2,3,4,6,7,8-HxCDF < 0.10 < 0.10 0.249 * 0.38 0.45 0.47 0.45 0.41 * 0.16 * * 0.23 0.15 0.47 0.12
1,2,3,7,8,9-HxCDF < 0.10 < 0.10 * 0.29 * 0.40 0.38 0.42 * * 0.18 0.17 0.13 0.28 0.16 0.37 <0.10
1,2,3,4,6,7,8-HpCDF 0.32 < 0.25 0.29 0.53 * 0.79 0.37 0.39 * <0.25 <0.25 <0.25 0.26 <0.25 <0.25 0.35 <0.25
1,2,3,4,7,8,9-HpCDF < 0.25 < 0.25 < 0.25 * * <0.25 <0.25 <0.25 <0.25 <0.25 <0.25 <0.25 <0.25 <0.25 <0.25 <0.25 <0.25
OCDF < 0.50 < 0.50 < 0.50 0.60 <0.50 <0.50 <0.50 0.71 0.56 <0.50 <0.50 1.12 * <0.50 <0.50 <0.50 <0.50
2.3.7.8-TCDD < 0.05 < 0.05 0.05 <0.05 0.15 0.13 0.19 0.23 0.15 0.24 0.22 0.16 0.13 0.27 0.13 0.19 0.11
1.2.3.7.8-PeCDD < 0.10 < 0.10 0.13 0.23 0.34 0.48 0.51 0.53 0.69 0.47 0.39 0.32 0.26 0.55 0.33 0.55 0.26
1.2.3.4.7.8-HxCDD < 0.10 < 0.10 0.19 0.42 * 0.57 0.60 0.50 0.47 0.30 0.28 * 0.17 0.35 0.27 0.53 0.17
1.2.3.6.7.8-HxCDD < 0.10 0.116 0.25 0.42 0.47 0.48 0.58 0.50 0.45 0.33 0.26 0.19 0.14 0.35 0.26 0.58 0.18
1.2.3.7.8.9-HxCDD < 0.10 < 0.10 0.17 0.36 0.39 0.42 0.44 0.49 0.38 0.21 0.17 0.11 <0.10 0.22 0.14 0.48 0.11
1.2.3.4.6.7.8-HpCDD 0.69 0.60 0.62 1.02 0.86 0.84 0.71 1.99 1.84 0.65 0.81 1.99 0.82 0.47 0.33 0.68 0.38
OCDD 4.48 3.67 3.17 5.56 3.91 4.09 4.03 21.90 18.50 4.72 7.58 40.80 11.90 1.66 1.29 3.54 3.59
Total level  [ub] 0.34 0.36 0.46 0.68 1.00 1.27 1.35 1.38 1.36 1.10 0.95 0.80 0.69 1.35 0.80 1.37 0.63
non-ortho PCBs         
PCB 81 0.98 1.14 2.08 3.41 4.19 5.41 7.96 7.95 8.18 7.27 6.64 5.66 4.72 9.78 5.78 7.10 4.41
PCB 77 14.80 17.90 26.30 30.20 27.40 29.60 33.90 37.10 35.10 28.70 27.20 25.10 19.20 39.50 19.70 27.30 17.20
PCB 126 1.92 1.82 2.96 5.08 5.87 7.35 9.17 8.53 8.56 7.17 6.57 5.53 4.67 9.44 6.84 8.57 4.56
PCB 169 0.33 0.45 2.32 4.87 6.82 7.16 7.89 7.97 6.90 4.15 3.50 2.86 2.25 6.15 5.41 7.75 2.39
Total level [ub] 0.20 0.19 0.32 0.56 0.66 0.81 1.00 0.94 0.93 0.76 0.70 0.58 0.49 1.01 0.74 0.94 0.48
 RIKILT rapport 2004.016 .
 eggs abdominal fat ovaries
Day 0 2 5 10 18 32 56 58 61 66 74 88 112 56 112 56 112
mono-ortho PCBs         
PCB 123 < 0.01 < 0.01 < 0.01 <0.01 0.01 0.01 0.02 0.02 0.02 * 0.01 0.01 0.01 0.02 0.01 0.02 <0.01
PCB 118 0.34 0.38 0.78 1.40 1.79 2.22 2.54 2.57 2.51 1.68 1.87 1.77 1.44 2.76 2.23 2.45 1.37
PCB 114 < 0.01 < 0.01 < 0.01 0.01 0.01 0.01 0.02 0.01 0.01 0.01 0.01 0.01 <0.01 0.02 0.01 0.01 <0.01
PCB 105 0.09 0.11 0.30 0.61 0.82 1.09 1.32 1.34 1.33 0.90 1.04 0.94 0.75 1.38 1.08 1.23 0.70
PCB 167 0.02 0.02 0.03 * * * * * * * 0.03 * * * 0.04 0.04 0.02
PCB 156 0.05 0.06 0.11 0.17 0.20 0.24 0.25 0.25 0.24 0.13 0.16 0.14 0.11 0.25 0.23 0.26 0.12
PCB 157 < 0.01 < 0.01 0.02 0.02 0.02 0.03 0.03 0.02 0.03 0.01 0.02 0.02 0.01 0.03 0.02 0.03 0.01
PCB 189 < 0.01 < 0.01 0.01 0.02 0.02 0.02 0.02 0.02 0.02 <0.01 0.01 <0.01 <0.01 0.02 0.02 0.02 <0.01
Total level [ub] 0.08 0.09 0.18 0.31 0.38 0.48 0.54 0.54 0.53 0.34 0.38 0.35 0.29 0.56 0.47 0.52 0.28
         
Sum [ub] 0.62 0.64 0.96 1.55 2.04 2.55 2.89 2.86 2.82 2.20 2.03 1.74 1.47 2.93 2.01 2.83 1.39
 
 RIKILT rapport 2004.016 . 
Appendix 3C. Levels of dioxins. non-ortho and mono-ortho PCBs in eggs, abdominal fat and ovaries from hens fed with feed C. Individual levels expressed in 
pg/g fat (dioxins, non-ortho PCBs) and ng/g fat (mono-ortho PCBs). Total levels expressed as pg TEQ/g fat. 
 
 Eggs abdominal fat ovaries 
Day 0 2 5 10 18 32 56 58 61 66 74 88 112 56 112 56 112
Dioxins         
2,3,7,8-TCDF < 0.50 < 0.50 < 1.0 <0.50 0.35 0.33 0.46 0.42 0.41 0.47 0.50 0.28 * 0.50 0.26 0.41 0.23
1,2,3,7,8-PeCDF < 0.10 < 0.10 0.24 * 0.62 0.82 * 0.94 * 0.75 0.86 0.74 0.53 0.85 0.44 * 0.34
2,3,4,7,8-PeCDF 0.11 0.16 0.28 0.52 0.76 0.82 0.94 0.95 1.00 0.74 0.90 0.63 0.46 0.83 0.44 0.98 0.40
1,2,3,4,7,8-HxCDF < 0.10 < 0.10 0.25 0.76 0.85 0.98 0.99 1.06 0.90 0.58 0.57 0.48 0.31 0.58 0.36 1.06 0.22
1,2,3,6,7,8-HxCDF < 0.10 < 0.10 0.28 0.62 0.82 0.81 0.95 0.93 0.78 0.50 0.49 0.34 0.24 0.47 0.29 0.94 0.24
2,3,4,6,7,8-HxCDF < 0.10 0.14 0.31 0.67 0.77 0.89 0.92 0.90 0.75 0.49 0.46 0.31 * 0.43 0.24 0.99 0.29
1,2,3,7,8,9-HxCDF < 0.10 < 0.10 0.20 * * 0.75 0.87 0.85 0.81 0.49 0.49 0.34 0.25 0.49 0.24 0.90 0.16
1,2,3,4,6,7,8-HpCDF <0.25 < 0.25 0.40 0.61 * 0.73 0.61 0.62 0.62 <0.25 * 0.44 0.44 <0.25 <0.25 0.60 <0.25
1,2,3,4,7,8,9-HpCDF < 0.25 < 0.25 < 0.25 * 0.44 0.47 0.43 0.48 0.38 <0.25 <0.25 <0.25 <0.25 <0.25 <0.25 0.48 <0.25
OCDF < 0.50 < 0.50 < 0.50 0.50 0.80 <0.50 0.63 0.87 0.84 <0.50 <0.50 0.64 2.70 <0.50 <0.50 0.53 <0.50
2.3.7.8-TCDD < 0.50 < 0.05 0.08 <0.05 0.25 0.29 0.40 0.34 0.46 0.49 0.54 0.23 0.33 0.47 0.22 0.42 0.22
1.2.3.7.8-PeCDD < 1.00 < 0.10 0.21 0.51 0.72 0.88 1.11 1.08 1.09 1.06 1.01 0.73 0.51 0.90 0.52 1.11 0.44
1.2.3.4.7.8-HxCDD < 0.25 < 0.10 0.28 0.86 * 1.07 1.16 1.11 1.00 0.75 0.65 0.43 0.27 0.68 0.43 1.22 0.28
1.2.3.6.7.8-HxCDD < 0.25 0.15 0.33 0.71 * 0.91 1.13 1.08 0.96 0.71 0.73 0.39 0.27 0.62 0.40 1.08 0.28
1.2.3.7.8.9-HxCDD < 0.25 < 0.10 0.28 0.66 0.76 0.94 0.94 0.89 0.79 0.47 0.51 0.28 0.19 0.46 0.25 0.96 0.16
1.2.3.4.6.7.8-HpCDD 0.73 0.62 0.78 1.13 1.17 1.07 1.10 1.11 1.28 0.68 1.07 1.11 1.71 0.44 0.44 1.13 0.39
OCDD 4.19 2.96 3.89 4.63 4.48 3.63 * 5.09 5.37 4.46 7.83 15.30 85.00 1.54 2.36 4.21 2.90
Total level  [ub] 0.34 0.38 0.75 1.34 1.78 2.31 2.75 2.69 2.71 2.41 2.50 1.62 1.30 2.26 1.24 2.81 1.07
non-ortho PCBs         
PCB 81 1.45 1.33 2.41 5.38 8.18 10.90 15.30 16.20 16.50 15.90 16.60 12.70 8.19 19.60 9.58 14.90 8.19
PCB 77 26.70 21.70 25.10 52.20 42.50 57.50 49.30 54.60 58.00 50.40 52.10 40.00 27.60 61.10 26.10 45.00 24.00
PCB 126 1.73 2.37 3.92 8.30 10.60 12.80 17.20 16.00 17.10 15.20 15.40 12.00 7.86 16.70 9.90 16.30 6.94
PCB 169 0.31 1.02 4.02 10.20 12.10 14.00 16.40 15.70 15.80 9.88 9.97 6.78 4.31 11.50 8.85 17.20 4.42
Total levels [ub] 0.18 0.25 0.43 0.94 1.19 1.43 1.89 1.76 1.88 1.63 1.65 1.27 0.83 1.79 1.08 1.81 0.74
 RIKILT rapport 2004.016 .
 Eggs abdominal fat ovaries 
Day 0 2 5 10 18 32 56 58 61 66 74 88 112 56 112 56 112
mono-ortho PCBs         
PCB 123 < 0.01 < 0.01 < 0.01 0.02 <0.01 0.02 0.03 0.03 0.03 0.03 0.03 0.02 0.01 0.03 <0.01 0.03 0.01
PCB 118 0.36 0.45 1.07 2.65 3.39 4.20 5.31 5.30 5.15 4.59 4.46 3.38 2.39 5.43 3.45 4.30 2.46
PCB 114 < 0.01 < 0.01 < 0.01 0.02 0.02 0.02 0.03 0.02 0.02 0.02 0.02 0.02 0.01 0.03 0.02 0.03 0.01
PCB 105 0.10 0.15 0.44 1.21 1.66 2.11 2.84 2.86 2.81 2.53 2.36 1.85 1.26 2.91 1.77 2.26 1.32
PCB 167 0.02 0.02 0.03 * * * * * * 0.04 0.05 * * * 0.05 0.05 0.03
PCB 156 0.06 0.07 0.15 0.33 0.38 0.44 0.53 0.50 0.48 0.38 0.36 0.25 0.18 0.43 0.33 0.44 0.20
PCB 157 < 0.01 0.01 0.02 0.03 0.04 0.04 0.05 0.05 0.04 0.04 0.04 0.02 0.02 0.04 0.03 0.04 0.02
PCB 189 < 0.01 < 0.01 0.02 0.03 0.03 0.04 0.04 0.04 0.03 0.02 0.02 0.01 <0.01 0.03 0.02 0.04 0.01
Total level [ub] 0.09 0.11 0.24 0.58 0.73 0.89 1.13 1.11 1.08 0.93 0.90 0.67 0.47 1.09 0.71 0.92 0.49
         
Sum [ub] 0.61 0.73 1.43 2.85 3.69 4.63 5.76 5.57 5.67 4.97 5.05 3.56 2.60 5.14 3.03 5.53 2.31
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Appendix 3D. Levels of dioxins. non-ortho and mono-ortho PCBs in eggs, abdominal fat and ovaries from hens fed with feed D. Individual levels expressed 
in pg/g fat (dioxins, non-ortho PCBs) and ng/g fat (mono-ortho PCBs). Total levels expressed as pg TEQ/g fat. 
 
 Eggs abdominal fat ovaries
Day 0 2 5 10 18 32 56 58 61 66 74 88 112 56 112 56 112
dioxins         
2,3,7,8-TCDF * * < 0.50 0.31 * 0.46 0.53 0.61 * 0.68 0.55 0.37 0.35 0.60 0.36 0.58 0.30
1,2,3,7,8-PeCDF < 0.10 < 0.10 0.26 0.69 * 1.12 1.19 1.4 1.33 1.26 0.97 0.78 0.59 1.12 0.56 1.29 0.48
2,3,4,7,8-PeCDF 0.11 0.13 0.32 0.76 0.74 1.16 1.17 1.43 1.38 1.17 1.03 0.67 0.62 1.17 0.61 1.31 0.51
1,2,3,4,7,8-HxCDF < 0.10 < 0.10 0.40 1.00 1.05 1.30 1.11 1.42 1.54 0.78 0.60 0.54 0.42 0.74 0.44 1.42 0.26
1,2,3,6,7,8-HxCDF < 0.10 < 0.10 0.37 0.95 0.97 1.14 1.02 1.27 1.36 0.71 0.52 0.36 0.26 0.62 0.35 1.22 0.26
2,3,4,6,7,8-HxCDF < 0.10 < 0.10 0.37 0.92 1.01 1.18 1.01 1.35 1.32 0.74 0.51 0.37 0.21 0.55 0.28 1.27 0.39
1,2,3,7,8,9-HxCDF < 0.10 < 0.10 0.31 0.82 0.88 1.06 1.05 1.17 * 0.76 0.56 0.41 0.28 0.67 0.34 1.15 0.21
1,2,3,4,6,7,8-HpCDF < 0.25 < 0.25 0.43 0.80 0.78 0.77 0.60 0.67 1.05 0.28 <0.25 0.40 0.36 0.28 <0.25 0.65 <0.25
1,2,3,4,7,8,9-HpCDF < 0.25 < 0.25 < 0.25 0.56 0.54 0.58 0.40 0.57 0.51 <0.25 <0.25 <0.25 <0.25 <0.25 <0.25 0.54 <0.25
OCDF < 0.50 < 0.50 < 0.50 0.98 0.87 0.56 0.59 0.84 0.88 <0.50 <0.50 0.61 0.54 <0.50 <0.50 <0.50 <0.50
2.3.7.8-TCDD < 0.05 < 0.05 0.05 0.21 0.26 0.44 0.59 0.52 0.33 0.75 0.54 0.45 0.31 0.56 0.33 0.52 0.28
1.2.3.7.8-PeCDD < 0.10 < 0.10 0.32 0.71 0.83 1.18 1.34 1.58 1.82 1.53 1.14 0.82 0.62 1.24 0.66 1.49 0.58
1.2.3.4.7.8-HxCDD < 0.10 < 0.10 0.42 1.15 1.09 1.50 1.34 1.68 1.50 1.09 0.76 0.50 0.38 0.91 0.57 1.61 0.34
1.2.3.6.7.8-HxCDD < 0.10 0.14 0.46 1.05 1.02 1.37 1.14 1.56 1.54 * 0.73 0.47 0.34 0.78 0.48 1.45 0.32
1.2.3.7.8.9-HxCDD < 0.10 < 0.10 0.37 1.01 0.96 1.19 1.00 1.27 1.16 0.73 * 0.32 0.19 0.57 0.29 1.22 *
1.2.3.4.6.7.8-HpCDD 0.64 0.56 0.78 1.46 1.16 1.34 0.99 1.26 1.50 0.90 0.75 0.85 0.73 0.51 0.42 0.99 0.41
OCDD 3.55 2.50 3.42 5.68 4.70 4.54 4.97 4.87 4.94 5.65 5.56 11.10 7.81 1.79 2.04 3.16 3.11
Total level  [ub] 0.32 0.33 0.87 2.08 2.20 3.21 3.42 3.94 3.79 3.50 2.69 2.00 1.52 2.99 1.65 3.75 1.37
non-ortho PCBs         
PCB 81 0.92 1.44 3.46 8.78 10.20 15.10 21.50 22.20 20.80 22.50 18.70 14.40 11.90 22.30 12.60 17.70 9.79
PCB 77 16.10 19.50 30.60 69.90 41.80 60.20 61.10 57.00 59.10 57.80 49.80 39.10 34.00 65.60 30.20 53.20 26.70
PCB 126 1.80 2.31 4.76 11.10 13.10 18.00 21.80 24.80 23.80 21.80 17.90 14.60 11.70 21.10 12.80 21.50 9.29
PCB 169 0.30 0.92 5.90 14.70 15.50 19.80 18.70 22.90 23.90 15.00 11.40 8.96 6.85 16.80 11.80 23.10 5.86
Total levels [ub] 0.18 0.24 0.54 1.26 1.47 2.01 2.38 2.72 2.63 2.34 1.91 1.55 1.24 2.29 1.40 2.39 0.99
 RIKILT rapport 2004.016 .
 Eggs abdominal fat ovaries
Day 0 2 5 10 18 32 56 58 61 66 74 88 112 56 112 56 112
mono-ortho PCBs         
PCB 123 < 0.01 < 0.01 0.01 0.02 0.02 0.04 0.04 0.04 0.04 0.04 0.03 0.02 0.02 0.04 0.02 0.04 0.02
PCB 118 0.36 0.50 1.50 3.53 4.36 6.07 7.20 8.02 7.82 6.20 5.72 4.62 3.73 7.09 4.51 6.37 3.28
PCB 114 < 0.01 < 0.01 0.01 0.02 0.02 0.03 0.03 0.03 0.04 0.03 0.03 0.02 0.02 0.03 0.02 0.03 0.02
PCB 105 0.10 0.16 0.66 1.63 2.13 3.17 3.90 4.28 4.26 3.76 3.29 2.54 2.02 3.86 2.34 3.35 1.75
PCB 167 0.02 0.02 0.04 * * * * * * 0.06 0.05 * * * 0.06 0.10 0.03
PCB 156 0.05 0.07 0.20 0.44 0.47 0.62 0.63 0.76 0.74 0.52 0.45 0.33 0.27 0.56 0.43 0.66 0.26
PCB 157 < 0.01 0.01 0.02 0.05 0.04 0.06 0.06 0.07 0.07 0.05 0.04 0.03 0.02 0.06 0.04 0.07 0.03
PCB 189 < 0.01 < 0.01 0.02 0.04 0.04 0.05 0.04 0.06 0.06 0.03 0.02 0.02 0.01 0.03 0.03 0.06 0.01
Total level [ub] 0.09 0.11 0.34 0.78 0.93 1.29 1.48 1.67 1.64 1.30 1.17 0.91 0.74 1.43 0.94 1.36 0.66
         
Sum [ub] 0.59 0.68 1.75 4.12 4.59 6.50 7.27 8.33 8.06 7.14 5.76 4.47 3.50 6.71 3.99 7.49 3.01
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Appendix 3E. Levels of dioxins. non-ortho and mono-ortho PCBs in eggs from hens fed with feed E. Individual levels expressed in pg/g fat (dioxins, non-
ortho PCBs) and ng/g fat (mono-ortho PCBs). Total levels expressed as pg TEQ/g fat. 
 
Day 0 2 5 10 18 32 56 57 (n=16) 58 61 66 74 88 112
dioxins  mean SD         
2,3,7,8-TCDF * 0.21 < 0.5 0.48 0.61 0.79 1.10 1.14 0.19 1.11 1.06 0.92 0.81 0.78 0.58
1,2,3,7,8-PeCDF < 0.10 0.20 0.60 1.48 1.87 2.55 2.86 3.22 0.54 2.98 2.66 1.93 1.76 1.87 1.28
2,3,4,7,8-PeCDF 0.132 0.14 0.65 1.44 2.00 2.72 2.83 3.27 0.46 3.07 2.64 1.98 1.71 1.76 1.25
1,2,3,4,7,8-HxCDF < 0.10 0.14 0.96 2.32 2.65 3.01 3.33 3.39 0.38 3.19 2.79 1.49 1.13 1.13 *
1,2,3,6,7,8-HxCDF < 0.10 < 0.10 1.01 2.17 2.47 2.82 2.98 3.06 0.35 3.09 2.53 1.33 1.01 0.88 0.61
2,3,4,6,7,8-HxCDF < 0.10 0.14 1.46 2.29 2.51 2.91 3.03 3.23 0.39 3.19 2.58 1.38 1.04 0.87 0.54
1,2,3,7,8,9-HxCDF < 0.10 0.13 0.75 1.93 2.25 2.48 2.85 2.89 0.34 2.92 2.39 1.41 1.06 1.06 0.67
1,2,3,4,6,7,8-HpCDF < 0.25 0.29 1.02 1.72 1.73 1.67 1.60 1.84 0.21 1.61 1.10 0.36 <0.25 0.35 0.37
1,2,3,4,7,8,9-HpCDF < 0.25 < 0.25 0.67 1.28 1.38 1.51 1.44 1.54 0.22 1.45 1.08 * <0.25 0.25 <0.25
OCDF < 0.50 < 0.50 0.69 1.31 1.02 1.10 0.98 1.73 0.77 1.11 0.72 <0.50 <0.50 0.69 0.61
2.3.7.8-TCDD < 0.05 0.18 0.18 0.33 0.69 1.00 1.31 1.36 0.27 1.32 1.22 1.14 0.95 0.98 0.69
1.2.3.7.8-PeCDD * < 0.25 0.57 1.78 2.01 2.81 3.39 3.66 0.60 3.93 3.13 2.39 2.15 2.05 1.46
1.2.3.4.7.8-HxCDD < 0.10 < 0.10 1.21 2.79 3.04 3.44 3.80 3.93 0.43 3.97 3.43 1.77 1.31 1.17 0.85
1.2.3.6.7.8-HxCDD 0.103 0.23 1.04 2.31 2.62 3.06 3.45 3.44 0.43 3.38 2.92 1.68 1.22 1.06 0.72
1.2.3.7.8.9-HxCDD < 0.10 < 0.10 0.99 2.25 2.57 2.75 2.87 3.13 0.37 2.96 2.52 1.21 0.94 0.75 0.54
1.2.3.4.6.7.8-HpCDD 0.583 0.55 1.31 2.21 2.30 2.18 2.15 2.60 0.44 2.40 1.53 0.85 0.63 1.00 1.03
OCDD 2.97 2.67 3.87 5.10 4.11 5.47 3.82 8.40 4.30 5.15 3.58 2.91 3.03 9.74 11.20
Total level  [ub] 0.33 0.64 1.92 4.61 5.72 7.48 8.65 9.29 1.37 9.37 7.86 5.75 4.91 4.78 3.32
non-ortho PCBs            
PCB 81 1.87 1.63 6.98 15.60 23.70 33.30 46.70 46.91 10.06 46.40 46.60 40.60 36.80 35.20 26.80
PCB 77 35.20 17.60 42.40 68.50 71.40 97.20 112.00 135.13 23.15 117.00 116.00 105.00 90.20 83.30 71.10
PCB 126 1.99 2.86 10.30 23.90 30.70 40.30 54.10 53.54 10.05 56.60 49.40 40.00 35.60 33.90 25.20
PCB 169 0.33 2.12 14.90 36.30 41.50 48.60 55.40 56.28 7.68 57.20 45.80 28.10 21.70 20.30 15.10
Total levels [ub] 0.21 0.31 1.18 2.76 3.49 4.53 5.98 5.93 1.08 6.25 5.41 4.30 3.79 3.60 2.68
            
 RIKILT rapport 2004.016 .
Day 0 2 5 10 18 32 56 57 (n=16) 58 61 66 74 88 112
dioxins  mean SD         
mono-ortho PCBs            
PCB 123 < 0.01 < 0.01 0.02 0.04 0.06 0.07 0.10 0.09 0.02 0.10 0.09 0.07 0.07 0.05 0.02
PCB 118 0.40 0.71 3.26 7.93 9.85 13.70 17.10 17.31 3.64 18.30 16.90 13.70 12.10 10.50 7.93
PCB 114 < 0.01 < 0.01 0.02 0.04 0.05 0.06 0.07 0.08 0.02 0.08 0.07 0.06 0.05 0.05 0.04
PCB 105 0.11 0.27 1.50 3.85 4.98 7.31 9.36 9.51 2.08 10.00 9.19 7.94 6.79 6.01 4.42
PCB 167 0.02 0.03 0.06 * * * 0.20 0.11 0.02 0.22 0.18 0.07 0.11 * *
PCB 156 0.06 0.10 0.44 1.00 1.17 1.39 1.75 1.66 0.29 1.84 1.55 1.04 0.90 0.73 0.55
PCB 157 0.01 0.01 0.05 0.10 0.11 0.13 0.15 0.15 0.03 0.16 0.14 0.10 0.08 0.07 0.05
PCB 189 < 0.01 0.01 0.04 0.10 0.11 0.12 0.14 0.13 0.01 0.14 0.11 0.05 0.04 0.03 0.02
Total level [ub] 0.09 0.16 0.74 1.76 2.16 2.91 3.66 3.65 0.74 3.90 3.51 2.78 2.41 2.09 1.55
            
Sum [ub] 0.63 1.11 3.84 9.13 11.38 14.92 18.29 18.88 3.16 19.52 16.79 12.82 11.11 10.48 7.55
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Appendix 3F. Levels of dioxins. non-ortho and mono-ortho PCBs in abdominal fat and ovaries from hens fed with feed E. Individual levels expressed in pg/g 
fat (dioxins, non-ortho PCBs) and ng/g fat (mono-ortho PCBs). Total levels expressed as pg TEQ/g fat. 
 
 abdominal fat ovaries 
Day 10 28 56 112 10 28 56 112 
Dioxins mean SD mean SD mean SD mean SD  mean SD mean SD mean SD mean SD  
2.3.7.8-TCDF 0.51 0.14 0.85 0.33 1.06 0.14 0.70 0.11 0.43 0.16 0.85 0.13 1.33 0.39 0.53 0.09
1.2.3.7.8-PeCDF 0.71 0.22 2.64 0.57 2.27 0.30 1.37 0.16 1.46 0.22 2.64 0.39 3.75 1.12 1.03 0.23
2.3.4.7.8-PeCDF 0.77 0.24 2.70 0.58 2.24 0.32 1.38 0.16 1.41 0.37 2.70 0.33 3.54 1.09 1.14 0.25
1.2.3.4.7.8-HxCDF 0.49 0.17 3.26 0.37 1.45 0.23 1.09 0.26 1.95 0.46 3.26 0.50 3.75 1.27 0.62 0.15
1.2.3.6.7.8-HxCDF 0.40 0.14 2.89 0.34 1.23 0.21 0.92 0.14 1.67 0.37 2.89 0.34 3.38 1.21 0.55 0.07
2.3.4.6.7.8-HxCDF 0.36 0.13 2.87 0.26 1.11 0.20 0.79 0.17 1.75 0.43 2.87 0.43 3.29 1.24 0.52 0.15
1.2.3.7.8.9-HxCDF 0.41 0.17 2.64 0.37 1.35 0.20 0.80 0.10 1.47 0.34 2.64 0.32 3.32 1.19 0.52 0.13
1.2.3.4.6.7.8-HpCDF 0.50 0.39 1.91 0.21 0.35 0.08 0.44 0.21 1.62 0.63 1.91 0.82 1.73 0.64 <0.25  
1.2.3.4.7.8.9-HpCDF < 0.25  1.47 0.05 0.33 0.06 0.30 0.04 1.04 0.25 1.47 0.33 1.63 0.66 <0.25  
OCDF < 0.50  2.30 4.14 <0.50  0.62 0.18 9.07 11.24 2.30 0.92 0.99 0.36 <0.50  
2.3.7.8-TCDD 0.35 0.13 1.00 0.29 1.18 0.18 0.73 0.06 0.43 0.28 1.00 0.19 1.45 0.49 0.63 0.12
1.2.3.7.8-PeCDD 0.69 0.27 3.00 0.59 2.62 0.43 1.63 0.16 1.42 0.38 3.00 0.41 4.23 1.32 1.24 0.24
1.2.3.4.7.8-HxCDD 0.53 0.22 3.71 0.49 1.79 0.26 1.35 0.21 2.16 0.49 3.71 0.46 4.43 1.61 0.87 0.15
1.2.3.6.7.8-HxCDD 0.53 0.17 3.18 0.38 1.54 0.26 1.19 0.29 1.89 0.31 3.18 0.39 3.84 1.24 0.75 0.16
1.2.3.7.8.9-HxCDD 0.36 0.14 2.94 0.30 1.11 0.19 0.79 0.19 1.70 0.42 2.94 0.37 3.32 1.20 0.52 0.08
1.2.3.4.6.7.8-HpCDD 0.63 0.19 2.43 0.77 0.60 0.13 1.43 1.47 3.25 2.28 2.43 0.76 2.26 0.85 0.78 0.14
OCDD 2.88 1.15 10.13 8.03 2.25 0.74 6.09 8.57 22.19 25.73 10.13 3.45 5.05 1.41 5.89 1.47
Total level [ub] 1.84 0.64 7.78 1.44 6.11 0.94 3.89 0.41 3.91 1.11 7.78 1.05 10.32 3.39 2.95 0.56
non-ortho-PCBs           
PCB 81 14.72 4.91 34.50 11.83 46.66 6.34 30.39 2.79 13.57 3.32 34.50 5.69 55.12 17.10 24.33 4.03
PCB 77 53.40 14.63 90.08 27.26 106.40 9.50 63.78 5.17 61.92 17.92 90.08 13.65 123.54 36.78 54.61 7.34
PCB 126 14.01 4.61 41.08 11.04 43.18 6.23 29.23 3.03 19.70 5.24 41.08 6.04 58.82 18.24 20.49 3.59
PCB 169 7.97 3.55 59.00 8.27 32.68 6.72 25.93 4.22 27.72 6.44 59.00 6.63 65.14 20.64 13.64 2.88
Total level [ub] 1.49 0.50 4.71 1.19 4.66 0.69 3.19 0.34 2.25 0.59 4.71 0.65 6.55 2.04 2.19 0.38
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 abdominal fat ovaries 
Day 10 28 56 112 10 28 56 112 
mono-ortho-PCBs           
PCB 123 0.03 0.01 0.08 0.02 0.09 0.01 0.06 0.01 0.04 0.01 0.08 0.01 0.09 0.01 0.04 0.01
PCB 118 5.26 2.70 13.36 4.00 15.90 2.49 10.93 1.26 6.48 1.77 13.36 1.99 16.28 2.15 6.88 1.20
PCB 114 0.03 0.01 0.06 0.02 0.07 0.01 0.05 0.01 0.03 0.01 0.06 0.01 0.07 0.01 0.03 0.01
PCB 105 2.83 1.50 7.03 2.18 8.76 1.33 5.72 0.63 3.11 0.87 7.03 1.10 8.79 1.12 3.86 0.68
PCB 167 0.07 0.03 *  *  0.10 0.01 * * 0.14 0.02 0.06 0.01
PCB 156 0.41 0.21 1.41 0.30 1.19 0.19 0.94 0.14 0.79 0.20 1.41 0.19 1.62 0.21 0.55 0.10
PCB 157 0.04 0.02 0.14 0.03 0.11 0.02 0.08 0.01 0.08 0.02 0.14 0.02 0.15 0.02 0.05 0.01
PCB 189 0.02 0.01 0.12 0.02 0.05 0.01 0.05 0.01 0.08 0.02 0.12 0.02 0.13 0.02 0.02 0.01
Total level [ub] 1.06 0.54 2.87 0.79 3.16 0.49 2.21 0.26 1.42 0.38 2.87 0.42 3.45 0.44 1.40 0.24
           
Sum [ub] 4.38 1.66 15.35 3.43 13.94 2.12 9.29 0.86 7.59 2.07 15.35 2.10 20.33 5.54 6.55 1.14
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Appendix 3G. Levels of dioxins. non-ortho and mono-ortho PCBs in eggs, abdominal fat and ovaries from hens fed with feed F. Individual levels expressed in 
pg/g fat (dioxins, non-ortho PCBs) and ng/g fat (mono-ortho PCBs). Total levels expressed as pg TEQ/g fat. 
 
 eggs abdominal fat ovaries
Day 0 2 5 10 18 32 56 58 61 66 74 88 112 56 112 56 112
dioxins             
2,3,7,8-TCDF < 0.50 < 1.0 nd 0.79 1.22 1.53 2.33 2.78 2.28 1.94 1.84 1.79 1.21 2.90 1.28 3.30 0.99
1,2,3,7,8-PeCDF < 0.25 < 0.25 nd 3.09 3.96 5.34 7.15 7.56 6.26 4.35 4.12 3.95 2.52 6.71 2.34 9.40 1.94
2,3,4,7,8-PeCDF 0.12 0.23 nd 3.03 3.90 5.33 6.76 7.37 5.91 4.17 4.24 3.97 2.58 6.60 2.41 9.36 2.20
1,2,3,4,7,8-HxCDF < 0.10 < 0.10 nd 4.65 5.46 5.78 7.00 7.18 6.05 3.17 2.56 2.31 1.46 4.66 1.71 9.55 1.16
1,2,3,6,7,8-HxCDF < 0.10 0.168 nd 4.31 4.92 5.26 6.44 6.49 5.23 2.84 2.25 1.88 1.19 4.01 1.36 8.80 0.99
2,3,4,6,7,8-HxCDF < 0.10 < 0.10 nd 4.42 5.13 5.58 6.80 6.94 5.60 2.81 2.32 1.90 1.15 3.60 1.14 8.60 0.88
1,2,3,7,8,9-HxCDF < 0.10 < 0.10 nd 3.75 4.41 5.03 6.28 6.23 4.99 3.08 2.67 1.99 1.15 4.23 1.23 8.38 0.97
1,2,3,4,6,7,8-HpCDF < 0.25 < 0.25 nd 3.41 3.24 3.15 3.26 3.02 2.16 0.62 0.44 0.69 0.45 0.97 0.57 4.04 <0.25
1,2,3,4,7,8,9-HpCDF < 0.25 < 0.25 nd 2.78 2.83 2.83 3.06 * 1.96 * * 0.33 <0.25 1.08 0.48 3.94 <0.25
OCDF < 0.50 < 0.50 nd 2.06 1.77 2.08 1.55 1.57 1.12 <0.50 <0.50 0.73 0.74 <0.50 <0.50 2.00 <0.50
2.3.7.8-TCDD < 0.05 < 0.25 nd 0.88 1.28 2.25 3.26 3.65 2.73 2.22 2.39 2.05 1.45 3.24 1.25 3.79 1.14
1.2.3.7.8-PeCDD < 0.10 < 0.50 nd 3.29 4.50 5.81 8.04 8.46 7.28 5.62 5.02 4.57 2.93 7.66 2.56 11.30 2.72
1.2.3.4.7.8-HxCDD < 0.10 0.24 nd 5.47 6.26 6.72 8.38 8.73 7.05 3.49 3.23 2.81 1.91 5.85 2.34 11.70 1.65
1.2.3.6.7.8-HxCDD < 0.10 0.25 nd 5.08 5.15 5.87 7.49 7.52 6.03 3.36 3.03 2.50 1.48 4.80 1.83 9.72 1.50
1.2.3.7.8.9-HxCDD < 0.10 0.16 nd 4.28 5.09 5.43 6.49 6.62 5.16 2.55 2.18 1.81 0.92 3.67 1.10 8.61 0.96
1.2.3.4.6.7.8-HpCDD 0.60 0.65 nd 4.08 3.89 3.99 3.97 3.85 2.90 0.92 0.87 1.87 1.02 1.34 0.95 5.34 0.52
OCDD 2.89 2.87 nd 7.75 5.14 8.96 4.78 4.51 4.58 2.96 3.27 20.70 9.83 1.76 4.34 11.00 2.84
Total level  [ub] 0.35 1.10 9.21 11.79 15.21 20.26 21.49 17.59 12.48 11.76 10.53 6.86 17.94 6.35 27.24 5.98
non-ortho PCBs             
PCB 81 1.5 1.9 nd 28.7 48.2 72.0 102.0 121.0 105.0 86.4 85.6 82.4 55.1 130.0 56.3 144.0 46.5
PCB 77 23.6 19.5 nd 84.4 119.0 181.0 252.0 251.0 240.0 203.0 181.0 162.0 115.0 252.0 100.0 292.0 84.6
PCB 126 2.2 3.8 nd 45.3 62.1 81.6 123.0 140.0 110.0 85.5 84.6 81.4 56.1 124.0 53.8 153.0 39.5
PCB 169 < 0.25 2.8 nd 69.4 84.9 94.3 124.0 126.0 99.5 57.4 54.8 54.4 37.2 104.0 52.2 163.0 29.5
Total levels [ub] 0.22 0.41 5.24 7.08 9.13 13.58 15.30 12.03 9.15 9.03 8.71 6.00 13.48 5.92 16.97 4.26
 RIKILT rapport 2004.016 .
 eggs abdominal fat ovaries
Day 0 2 5 10 18 32 56 58 61 66 74 88 112 56 112 56 112
mono-ortho PCBs             
PCB 123 < 0.01 < 0.01 nd nd 0.12 0.14 0.22 0.24 0.20 0.16 0.15 0.13 0.08 0.23 0.10 0.26 0.07
PCB 118 0.40 0.92 nd nd 20.50 28.20 40.60 44.80 38.00 29.00 29.30 24.90 17.00 41.00 19.20 41.00 13.70
PCB 114 < 0.01 < 0.01 nd nd 0.08 0.12 0.16 0.18 0.16 0.13 0.12 0.10 0.07 0.18 0.08 0.21 0.06
PCB 105 0.11 0.38 nd nd 10.60 15.10 23.00 25.00 21.40 17.30 16.50 14.00 9.23 23.00 10.20 23.90 7.74
PCB 167 0.02 0.03 nd nd * * 0.41 0.40 0.35 0.23 0.21 * * 0.16 0.18 0.39 0.10
PCB 156 0.06 0.13 nd nd 2.39 2.74 4.03 4.28 3.41 2.27 2.17 1.82 1.25 3.37 1.79 4.45 1.13
PCB 157 0.01 0.02 nd nd 0.22 0.25 0.39 0.38 0.31 0.21 0.19 0.17 0.10 0.27 0.14 0.43 0.11
PCB 189 < 0.01 0.01 nd nd 0.22 0.22 0.29 0.30 0.23 0.11 0.10 0.08 0.05 0.16 0.11 0.33 0.05
Total level [ub] 0.09 0.21 4.49 5.92 8.70 9.46 7.93 5.96 5.84 4.95 3.35 8.35 3.97 9.09 2.81
             
Sum [ub] 0.67 1.72 23.35 30.26 42.54 46.25 37.55 27.60 26.64 24.20 16.21 39.77 16.24 53.31 13.04
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Appendix 4A. Levels of indicator PCBs in eggs, abdominal fat and ovaries of hens fed with blank feed A. Individual levels in ng/g fat. 
 
 eggs abdominal fat ovaries
Day 0 2 5 10 18 32 56 58 61 66 74 88 112 56 112 56 112
              
PCB 28 <0.4 0.5 <0.4 <0.4 <0.4 <0.4 <0.4 <0.4 <0.4 <0.4 0.5 <0.4 <0.4 0.4 0.5 0.5 0.6
PCB 52 0.5 0.5 0.5 0.5 0.6 0.5 0.5 0.5 0.6 0.5 0.6 0.5 0.5 0.4 <0.4 0.5 <0.4
PCB 101 <0.4 <0.4 <0.4 <0.4 <0.4 <0.4 <0.4 <0.4 <0.4 <0.4 <0.4 <0.4 <0.4 <0.4 <0.4 <0.4 <0.4
PCB 118 <0.4 <0.4 <0.4 <0.4 <0.4 <0.4 <0.4 <0.4 <0.4 <0.4 <0.4 <0.4 <0.4 <0.4 <0.4 <0.4 <0.4
PCB 138 1.17 1.2 1.0 1.2 1.2 1.1 0.9 1.1 1.0 1.0 1.0 0.8 0.8 1.2 0.8 0.9 0.6
PCB 153 1.00 1.0 0.9 1.0 0.9 0.9 0.8 0.8 0.8 0.8 0.8 0.7 0.7 1.2 0.8 0.8 0.6
PCB 180 0.83 0.7 0.5 0.8 0.5 0.5 <0.4 <0.4 <0.4 <0.4 <0.4 <0.4 0.4 0.8 0.9 0.5 0.8
Total level  [ub] 3.5 3.8 2.9 3.5 3.2 2.9 2.2 2.4 2.4 2.3 2.9 2.0 2.4 3.9 3.7 3.1 3.4
 
Appendix 4B. Levels of indicator PCBs in eggs, abdominal fat and ovaries of hens fed with feed B. Individual levels in ng/g fat. 
 
 eggs abdominal fat ovaries
Day 0 2 5 10 18 32 56 58 61 66 74 88 112 56 112 56 112
            
PCB 28 <0.4 0.4 <0.4 0.6 1.0 1.4 1.8 1.9 1.7 1.9 1.7 1.3 1.1 1.9 1.4 1.6 1.5
PCB 52 0.5 0.5 0.6 0.7 0.7 0.8 0.8 1.1 1.1 0.8 0.9 0.7 0.8 0.5 <0.4 0.6 <0.4
PCB 101 <0.4 <0.4 0.4 0.6 0.7 0.7 0.7 0.8 0.6 0.4 <0.4 <0.4 <0.4 0.6 <0.4 0.5 <0.4
PCB 118 <0.4 <0.4 0.7 1.3 1.6 2.0 2.6 2.6 2.4 2.1 1.8 1.6 1.4 2.4 2.0 2.1 1.5
PCB 138 1.1 1.2 2.1 3.7 4.4 4.9 5.5 5.8 5.4 4.1 3.6 3.1 2.8 5.0 4.8 5.0 3.0
PCB 153 1.0 1.0 2.0 3.8 4.4 5.0 5.8 5.8 5.3 3.8 3.2 2.8 2.4 4.9 4.9 5.0 2.8
PCB 180 0.6 1.2 1.8 4.3 3.8 4.6 4.5 5.5 4.7 2.6 2.7 1.7 1.9 2.9 3.4 4.2 1.7
Total level  [ub] 3.2 4.3 7.7 15.2 16.5 19.3 21.7 23.5 21.2 15.7 14.1 11.2 10.3 18.2 16.9 19.0 11.0
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Appendix 4C. Levels of indicator PCBs in eggs, abdominal fat and ovaries of hens fed with feed C. Individual levels in ng/g fat. 
 
 eggs abdominal fat ovaries
Day 0 2 5 10 18 32 56 58 61 66 74 88 112 56 112 56 112
            
PCB 28 0.5 0.6 1.2 1.5 2.3 3.1 3.0 3.3 3.4 3.6 2.2 1.6 3.4 2.1 3.0 1.8
PCB 52 <0.4 0.5 0.7 0.8 0.8 0.7 0.6 0.6 <0.4 <0.4 <0.4 <0.4 0.7 <0.4 0.8 <0.4
PCB 101 <0.4 0.5 1.0 0.9 1.0 1.0 1.0 0.7 <0.4 <0.4 <0.4 <0.4 1.1 <0.4 0.9 <0.4
PCB 118 0.4 0.9 2.2 2.5 3.4 4.5 4.5 4.4 4.2 4.6 2.7 1.9 4.8 3.2 4.5 2.3
PCB 138 1.3 2.8 6.3 6.8 8.4 10.6 10.7 9.8 8.3 8.2 5.3 3.6 9.4 7.0 10.8 4.5
PCB 153 1.1 2.9 6.9 7.2 8.9 10.7 11.0 9.7 7.7 8.4 4.9 3.4 9.2 7.2 10.6 4.2
PCB 180 0.8 2.6 6.2 6.3 7.5 8.5 8.4 6.9 4.0 4.5 2.4 1.7 4.7 4.8 8.6 2.5
Total level  [ub] 4.1 10.9 24.4 26.0 32.3 39.0 39.3 35.5 27.6 29.3 17.6 12.3 33.3 24.7 39.2 15.7
 
Appendix 4D. Levels of indicator PCBs in eggs, abdominal fat and ovaries of hens fed with feed D. Individual levels in ng/g fat. 
 
 eggs abdominal fat ovaries
Day 0 2 5 10 18 32 56 58 61 66 74 88 112 56 112 56 112
            
PCB 28 <0.4 0.6 0.6 1.3 2.1 3.0 4.3 4.1 4.1 3.5 3.3 2.8 2.4 4.4 2.7 3.9 2.5
PCB 52 <0.4 <0.4 0.7 1.0 0.9 1.0 0.8 0.9 0.9 0.5 0.4 <0.4 0.5 0.9 <0.4 0.9 0.4
PCB 101 <0.4 <0.4 0.8 1.5 1.4 1.6 1.0 1.4 1.4 <0.4 <0.4 <0.4 <0.4 1.5 <0.4 1.3 <0.4
PCB 118 0.3 0.5 1.4 3.0 3.8 5.2 6.4 6.8 6.6 4.7 4.2 3.8 3.2 6.3 4.3 5.9 3.1
PCB 138 0.8 1.3 3.7 8.0 8.9 11.9 13.2 14.9 14.9 8.9 8.7 7.5 6.0 12.6 9.2 14.2 6.1
PCB 153 0.8 1.2 3.9 8.7 9.9 12.4 12.7 15.0 15.2 8.0 7.5 6.8 5.4 12.3 9.4 14.1 5.8
PCB 180 0.5 0.9 3.9 8.9 9.1 10.8 9.4 12.0 12.1 4.6 4.3 3.5 2.8 5.6 6.2 11.4 3.2
Total level  [ub] 2.4 4.3 15.0 32.5 36.1 45.8 47.8 55.1 55.2 30.2 28.3 24.4 20.3 43.6 32.2 51.6 21.2
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Appendix 4E. Levels of indicator PCBs in eggs of hens fed with feed E. Individual levels in ng/g fat. 
 
 eggs 
Day 0 2 5 10 18 32 56 58 61 66 74 88 112
          
PCB 28 0.5 0.6 1.1 2.4 3.9 6.5 8.4 9.1 9.8 8.6 7.5 6.4 4.7
PCB 52 0.6 0.6 1.1 1.8 1.7 1.9 1.6 1.5 1.6 0.7 0.5 0.4 0.5
PCB 101 <0.4 0.4 1.9 3.0 3.2 3.4 3.5 3.6 2.6 0.8 0.5 <0.4 <0.4
PCB 118 <0.4 0.7 2.8 6.1 8.0 11.7 14.8 16.3 15.7 12.1 10.0 8.9 6.6
PCB 138 1.0 2.0 8.9 18.4 21.6 29.6 34.6 38.4 35.1 24.0 18.2 16.5 12.7
PCB 153 1.0 2.1 9.9 20.5 24.3 30.9 36.1 40.0 36.3 22.5 18.2 15.5 11.7
PCB 180 0.4 1.5 8.4 17.9 19.5 23.1 25.6 28.2 23.4 11.4 8.1 6.6 4.9
Total level  [ub] 3.4 7.9 34.2 70.1 82.2 106.9 124.7 137.1 124.5 80.0 63.1 54.3 41.1
 
Appendix 4F. Levels of indicator PCBs in abdominal fat and ovaries of hens fed with feed E. Individual levels in ng/g fat. 
 
 abdominal fat ovaries 
Day 10 28 56 112 10 28 56 112 
 mean. SD mean SD mean SD mean SD  mean. SD mean SD mean SD mean SD  
PCB 28 3.1 0.9 7.2 1.1 9.6 1.5 5.7 0.4 2.7 0.7 6.8 1.0 9.0 1.3 5.0 0.8
PCB 52 1.5 0.4 1.6 0.2 1.3 0.1 0.4 0.0 1.5 0.3 1.7 0.3 1.5 0.2 0.5 0.1
PCB 101 2.2 0.9 3.3 0.8 3.1 0.3 0.5 0.1 2.8 0.7 3.7 0.8 3.2 0.4 <0.4  
PCB 118 4.2 1.6 8.9 1.7 12.6 2.0 9.3 1.0 5.9 1.4 11.9 1.4 14.7 2.2 6.8 1.1
PCB 138 7.4 3.1 15.6 3.4 22.8 3.6 19.7 2.3 16.8 3.8 30.1 3.3 34.8 4.8 12.8 2.1
PCB 153 7.2 3.0 15.1 3.3 22.1 3.6 19.6 2.5 18.2 4.1 31.7 3.7 35.6 4.8 12.2 2.1
PCB 180 3.6 1.3 8.8 2.2 13.2 2.2 11.2 1.8 17.4 3.5 26.8 2.8 27.8 3.7 6.4 1.4
Total level  [ub] 29.3 11.1 60.5 12.5 84.8 12.9 66.2 7.8 65.1 14.4 112.7 13.1 126.6 16.5 43.8 6.7  
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Appendix 4G. Levels of indicator PCBs in eggs, abdominal fat and ovaries of hens fed with feed F. Individual levels in ng/g fat. 
 
 eggs abdominal fat ovaries 
Day 0 2 5 10 18 32 56 58 61 66 74 88 112 56 112 56 112
              
PCB 28 0.5 0.6 nd 4.5 8.2 14.2 20.7 24.0 21.5 17.4 17.4 14.2 9.5 25.3 10.3 23.5 9.5
PCB 52 <0.4 0.5 nd 2.6 2.6 2.4 2.9 3.2 2.2 0.7 <0.4 <0.4 <0.4 2.4 <0.4 2.8 0.4
PCB 101 <0.4 0.5 nd 5.9 6.3 6.1 7.5 8.6 5.1 1.3 0.7 <0.4 <0.4 6.6 <0.4 6.6 <0.4
PCB 118 <0.4 0.9 nd 12.2 17.8 25.9 38.5 43.7 36.5 25.9 26.1 23.2 15.9 36.0 18.0 38.4 14.9
PCB 138 1.0 2.6 nd 34.2 46.3 57.0 83.1 88.0 77.5 49.5 45.3 43.1 29.6 66.6 39.9 88.8 28.5
PCB 153 1.0 2.7 nd 39.1 50.8 61.1 86.2 93.2 77.8 46.9 45.5 41.1 28.3 65.4 40.4 90.3 27.5
PCB 180 0.5 2.1 nd 34.3 41.4 44.1 58.5 60.3 49.4 23.2 20.0 17.7 12.1 41.1 25.6 65.4 13.8
Total level  [ub] 3.0 9.8 nd 132.7 173.4 210.8 297.3 321.0 270.0 165.0 155.1 139.4 95.4 243.5 134.8 315.9 94.8
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Appendix 5. Levels of dioxins, non-ortho and mono-ortho PCBs in the different feeds used in study B. Results are expressed as the mean of 3 to 5 analyses, 
with the standard deviation and the variation coefficient. Individual levels in  ng/kg. Total levels expressed in ng TEQ/kg. 
 
 Soil A Soil B Feed E Feed E + sand 10% soil A 10% soil B 
   mean SD %CV mean SD %CV mean SD %CV mean SD %CV 
Dioxins               
2,3,7,8-TCDF 1.1 0.45 0.11 0.00 4 0.10 0.01 6 0.12 0.03 24 0.09 0.02 22 
1,2,3,7,8-PeCDF 1.1 0.53 0.24 0.02 7 0.23 0.02 7 0.11 0.04 33 0.10 0.03 30 
2,3,4,7,8-PeCDF 1.5 0.72 0.26 0.01 3 0.24 0.01 3 0.18 0.04 20 0.15 0.02 16 
1,2,3,4,7,8-HxCDF 1.7 1.1 0.29 0.01 5 0.25 0.01 2 0.17 0.04 23 0.13 0.03 19 
1,2,3,6,7,8-HxCDF 1.4 0.78 0.26 0.01 4 0.24 0.01 3 0.14 0.04 27 0.11 0.03 26 
2,3,4,6,7,8-HxCDF 2.3 1.2 0.23 0.05 20 0.23 0.01 6 0.21 0.05 23 0.13 0.02 15 
1,2,3,7,8,9-HxCDF 0.41 0.34 0.24 0.02 10 0.22 0.02 7 0.07 0.04 49 0.08 0.02 22 
1,2,3,4,6,7,8-HpCDF 43 17 0.99 0.48 49 0.53 0.04 8 3.59 0.47 13 1.22 0.08 7 
1,2,3,4,7,8,9-HpCDF 0.86 0.55 <0.25   <0.25   0.10 0.04 37 0.08 0.03 33 
OCDF 32 15 1.04 0.30 29 0.68 0.03 4 2.90 0.42 14 1.25 0.09 8 
2,3,7,8-TCDD 0.15 0.065 0.10 0.01 9 0.09 0.01 8 0.04 0.03 68 0.04 0.01 33 
1,2,3,7,8-PeCDD 0.76 0.37 0.26 0.02 9 0.24 0.01 4 0.09 0.04 44 0.07 0.04 58 
1,2,3,4,7,8-HxCDD 0.86 0.28 0.29 0.02 6 0.27 0.02 8 0.12 0.04 37 0.08 0.03 43 
1,2,3,6,7,8-HxCDD 3.6 0.76 0.29 0.03 11 0.23 0.01 4 0.34 0.05 13 0.11 0.03 27 
1,2,3,7,8,9-HxCDD 1.8 1.5 0.30 0.02 6 0.26 0.00 1 0.18 0.04 25 0.10 0.03 34 
1,2,3,4,6,7,8-HpCDD 52 10 1.07 0.57 54 0.47 0.02 4 4.06 0.47 12 0.91 0.06 6 
OCDD 286 61 5.62 3.86 69 1.99 0.06 3 23.85 3.06 13 5.26 0.52 10 
Total level  [ub] 4.0 1.7 0.73 0.03 5 0.65 0.02 4 0.44 0.12 26 0.29 0.09 30 
non-ortho-PCBs               
PCB 81 0.29 0.19 3.85 0.43 11 3.60 224 6 0.60 0.63 105 0.86 0.52 60 
PCB 77 4.3 3.1 8.62 0.80 9 7.93 381 5 1.79 1.35 76 2.25 1.07 48 
PCB 126 3.2 1.4 3.88 0.35 9 3.55 164 5 0.90 0.67 74 0.99 0.53 53 
PCB 169 0.63 0.38 3.71 0.36 10 3.47 202 6 0.61 0.68 112 0.83 0.51 61 
Total level [ub] 0.32 0.15 0.43 0.04 9 0.39 0.02 5 0.10 0.07 76 0.11 0.06 54 
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 Soil A Soil B Feed E Feed E + sand 10% soil A 10% soil B 
   mean SD %CV mean SD %CV mean SD %CV mean SD %CV 
mono-ortho PCBs               
PCB 123 * * <10   <10   <10   <10   
PCB 118 170 52 1288 121 9 1183 68 6 193 231 119 296 169 57 
PCB 114 <10 <10 <10   <10   <10   <10   
PCB 105 68 21 719 70 10 657 25 4 128 139 108 206 64 31 
PCB 167 29 <10 <10   <10   <10   <10   
PCB 156 61 17 115 10 8 105 6 5 44 8 18 44 23 51 
PCB 157 13 <10 11 0 2 <10   <10   <10   
PCB 189 <10 <10 <10   <10   <10   <10   
Total level [ub] 0.07 0.03 0.27 0.02 9 0.25 0.01 5 0.05 0.05 85 0.08 0.05 59 
Sum [lb] 4.4 1.9 1.41   1.28   0.53   0.37   
Som [ub] 4.4 1.9 1.42 0.09 7 1.29 0.05 4 0.64 0.17 27 0.54 0.13 23 
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Appendix 6. Levels of dioxins, non-ortho and mono-ortho PCBs in eggs from hens fed with feed E, feed E mixed with 10% sand or the blank feed A mixed 
with 10% soil A or soil B. Individual levels expressed in pg/g fat (dioxins. non-ortho PCBs) and ng/g fat (mono-ortho PCBs). Total levels expressed as pg 
TEQ/g fat. 
 
 feed E feed E + 10% sand feed A with 10% soil A Feed A with 10% soil B 
Day t=0 5 10 14 22 32 5 10 14 22 32 5 10 14 22 32 5 10 14 22 32
dioxins      
2,3,7,8-TCDF 0.32 0.54 0.81 1.02 0.98 1.02 0.51 0.71 0.73 0.96 1.09 0.33 0.53 0.66 0.72 0.79 0.49 0.46 0.55 0.64 0.50
1,2,3,7,8-PeCDF 0.17 0.67 1.76 2.40 * 2.63 0.72 1.53 * 2.67 2.65 0.17 * * 0.64 0.62 0.32 * * 0.53 *
2,3,4,7,8-PeCDF 0.43 0.90 2.04 2.38 2.56 2.41 0.90 1.57 1.72 2.41 2.47 0.43 0.88 0.88 1.09 0.85 0.55 0.71 0.68 0.81 0.84
1,2,3,4,7,8-HxCDF 0.29 0.88 2.33 3.13 2.87 2.84 0.84 2.10 2.32 2.76 3.10 0.28 1.00 1.22 1.29 1.25 0.54 0.67 0.86 0.93 0.88
1,2,3,6,7,8-HxCDF 0.11 0.71 2.45 2.89 2.59 2.66 0.71 1.91 2.03 2.61 2.72 * 0.71 0.96 1.00 1.01 0.33 0.46 0.59 0.64 0.63
2,3,4,6,7,8-HxCDF * 0.66 2.61 2.71 2.60 3.22 0.70 1.83 2.42 2.52 1.33 0.26 0.97 1.54 1.30 1.58 * 0.59 0.91 0.78 1.00
1,2,3,7,8,9-HxCDF <0.10 0.59 1.91 2.51 2.38 2.48 0.62 1.71 1.80 2.37 2.57 <0.10 <0.10 0.25 <0.10 0.16 <0.10 <0.10 0.10 <0.10 0.11
1,2,3,4,6,7,8-HpCDF <0.25 0.72 1.43 1.74 1.45 1.46 0.62 1.25 1.29 1.54 1.47 * 10.90 11.80 12.70 10.50 * 4.26 5.21 4.82 3.70
1,2,3,4,7,8,9-HpCDF <0.25 0.46 1.32 1.51 1.33 1.22 0.45 1.11 1.11 1.30 1.40 <0.25 0.26 0.30 0.32 0.30 <0.25 <0.25 <0.25 <0.25 <0.25
OCDF <0.50 0.52 0.95 1.08 0.95 0.75 0.59 0.80 0.77 0.85 1.04 * 3.40 3.52 3.81 * 1.44 1.73 2.02 1.87 1.43
2.3.7.8-TCDD 0.10 0.13 0.55 0.76 0.86 0.94 0.15 0.39 0.56 0.80 1.19 <0.05 <0.05 0.19 0.08 0.08 <0.05 0.07 0.05 <0.05 0.08
1.2.3.7.8-PeCDD 0.11 0.47 1.86 2.69 2.64 2.99 0.48 1.54 1.82 2.57 3.11 <0.10 0.26 0.42 0.39 0.53 0.13 <0.10 0.14 0.17 0.13
1.2.3.4.7.8-HxCDD <0.10 0.71 2.69 3.56 3.37 3.36 0.67 2.25 2.64 3.17 3.51 <0.10 0.51 0.67 0.71 0.69 * 0.18 * 0.28 *
1.2.3.6.7.8-HxCDD 0.16 0.76 2.42 3.07 2.84 3.10 0.70 2.13 2.32 2.71 2.99 0.24 2.72 3.38 3.65 3.47 0.82 0.64 0.78 0.84 0.80
1.2.3.7.8.9-HxCDD <0.10 0.69 2.25 2.85 2.73 2.59 0.62 1.93 2.05 2.61 2.68 0.13 0.88 0.97 1.20 1.11 * 0.33 0.49 0.46 0.43
1.2.3.4.6.7.8-HpCDD 1.32 1.07 1.85 2.25 1.82 1.95 1.01 1.57 1.63 1.80 1.90 1.57 18.90 20.30 23.30 18.60 5.36 3.83 5.58 4.93 4.18
OCDD 14.76 3.61 4.55 4.89 3.66 4.18 3.07 3.12 3.37 3.51 3.83 5.62 75.20 71.10 94.00 66.90 20.10 12.10 15.40 18.20 11.40
Total level  [ub] 0.55 1.66 5.31 6.99 6.87 7.44 1.67 4.29 4.92 6.73 7.71 0.55 1.80 2.35 2.41 2.37 0.78 0.96 1.08 1.22 1.16
non-ortho PCBs      
PCB 81 0.6 4.5 18.4 27.2 31.8 40.3 4.0 15.7 19.1 29.4 36.3 0.4 0.6 1.3 0.6 0.7 0.5 0.5 0.6 0.5 0.7
PCB 77 11.0 13.6 41.6 69.5 70.6 95.2 13.0 36.6 51.6 65.5 91.0 4.6 6.2 15.4 6.8 16.2 * 5.9 11.8 6.2 12.4
PCB 126 1.4 8.0 27.3 37.8 39.2 47.4 7.2 22.8 26.3 37.1 44.2 1.6 2.9 3.7 3.6 4.0 1.9 2.0 2.2 2.4 2.3
PCB 169 0.3 10.8 39.1 51.7 48.0 50.8 9.5 32.6 37.2 46.0 48.8 0.2 0.8 1.3 1.0 * * 0.5 0.7 0.6 0.8
Total levels [ub] 0.15 0.91 3.13 4.31 4.41 5.26 0.81 2.61 3.01 4.18 4.92 0.16 0.30 0.38 0.37 0.40 0.19 0.21 0.23 0.25 0.24
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 feed E feed E + 10% sand feed A with 10% soil A Feed A with 10% soil B 
Day t=0 5 10 14 22 32 5 10 14 22 32 5 10 14 22 32 5 10 14 22 32
mono-ortho PCBs      
PCB 123 <0.01 0.02 0.05 0.07 0.07 0.08 0.11 0.04 0.05 0.07 0.08 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 * * * *
PCB 118 0.25 2.36 8.53 12.00 12.40 14.70 2.24 7.10 8.60 12.30 13.90 0.27 0.33 0.38 0.34 0.39 0.33 0.27 0.29 0.26 0.29
PCB 114 0.01 0.01 0.04 0.05 0.05 0.06 0.10 0.03 0.03 0.05 0.05 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01
PCB 105 0.07 1.09 4.19 6.24 6.38 8.14 1.06 3.52 4.54 6.41 7.72 0.08 0.10 0.12 0.11 0.13 0.09 0.08 0.09 0.08 0.09
PCB 167 0.03 0.06 0.12 0.16 0.14 0.15 0.12 0.11 0.13 0.14 0.15 0.03 0.05 0.04 0.05 0.04 0.05 0.03 0.03 0.03 0.03
PCB 156 0.07 0.34 1.06 1.40 1.34 1.48 0.37 0.90 1.03 1.31 1.40 0.06 0.11 0.12 0.11 0.11 0.10 0.07 0.07 0.07 0.07
PCB 157 <0.01 0.03 0.10 0.12 0.12 0.12 0.07 0.09 0.09 0.13 0.13 <0.01 * 0.02 0.02 0.02 0.01 <0.01 0.01 0.01 0.01
PCB 189 0.02 0.04 0.11 0.13 0.12 0.12 0.06 0.09 0.10 0.12 0.12 0.01 0.02 0.02 0.02 0.02 0.02 0.01 0.01 0.01 *
Total level [ub] 0.08 0.54 1.89 2.63 2.65 3.14 0.62 1.59 1.91 2.63 2.98 0.08 0.11 0.12 0.12 0.12 0.11 0.08 0.09 0.08 0.08
      
Sum [ub] 0.77 3.11 10.32 13.93 13.93 15.84 3.10 8.48 9.84 13.54 15.61 0.79 2.20 2.85 2.90 2.90 1.08 1.25 1.40 1.55 1.48
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Appendix 7. Levels of indicator PCBs in eggs from hens fed with feed E, feed E mixed with 10% sand or the blank feed A mixed with 10% soil A or soil B. 
Individual levels expressed in ng/g fat. 
 
 t=0 feed E feed E + 10% sand feed A with 10% soil A feed A with 10% soil B 
Day 0 5 10 14 22 32 5 10 14 22 32 5 10 14 22 32 5 10 14 22 32
      
PCB 28 0.97 1.49 3.71 5.29 7.35 9.23 1.18 3.26 3.78 6.48 7.80 0.96 0.86 0.56 0.90 0.43 1.06 0.58 <0.4 0.72 <0.4
PCB 52 <0.40 1.27 1.95 2.08 2.01 2.07 0.82 1.82 1.91 2.59 2.08 0.49 0.41 0.55 0.45 0.52 0.78 0.45 0.41 0.61 <0.4
PCB 101 0.55 2.52 4.56 5.64 4.94 5.60 1.84 4.72 4.84 5.23 5.88 0.75 0.64 1.09 0.57 0.99 1.15 0.64 0.84 0.65 0.74
PCB 118 0.55 2.93 7.79 11.07 12.23 15.31 2.13 7.00 8.04 10.76 13.18 0.76 0.65 0.95 0.61 0.92 1.06 0.68 0.77 0.69 0.72
PCB 138 1.94 8.46 20.28 26.56 28.41 34.04 6.53 19.23 20.25 26.26 30.12 2.41 2.02 3.13 2.05 3.15 3.80 2.66 2.34 2.86 2.08
PCB 153 1.40 8.76 23.23 30.98 32.39 36.74 6.77 21.25 22.49 28.12 32.44 1.72 1.49 2.35 1.49 2.25 2.56 2.03 1.57 2.11 1.58
PCB 180 0.76 6.89 20.52 27.83 26.68 28.64 6.02 19.25 20.66 22.53 25.62 0.91 0.64 1.82 0.75 1.65 1.23 1.19 1.27 1.10 1.29
Total level  [ub] 6.52 32.32 82.04 109.45 114.02 131.62 25.29 76.54 81.97 101.96 117.12 8.00 6.71 10.45 6.83 9.90 11.64 8.22 7.51 8.73 7.16
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Appendix 8. Levels of dioxins, non-ortho and mono-ortho PCBs in abdominal fat from hens fed with feed E, feed E mixed with 10% sand or the blank feed A 
mixed with 10% soil A or soil B for 32 days. Individual levels expressed in pg/g fat (dioxins, non-ortho PCBs) and ng/g fat (mono-ortho PCBs). Total levels 
expressed as pg TEQ/g fat. 
 
 feed E feed E + 10% sand feed A with 10% soil A feed A with 10% soil B 
Day  mean SD mean SD mean SD mean SD 
Dioxins          
2,3,7,8-TCDF 1.13 0.16 1.08 0.17 0.81 0.12 0.59 0.06 
1,2,3,7,8-PeCDF 2.31 0.41 2.08 0.37 0.50 0.04 0.43 0.06 
2,3,4,7,8-PeCDF 2.36 0.37 2.14 0.35 0.90 0.07 0.76 0.10 
1,2,3,4,7,8-HxCDF 1.46 0.26 1.31 0.25 0.59 0.06 0.47 0.11 
1,2,3,6,7,8-HxCDF 1.36 0.29 1.16 0.18 0.44 0.07 0.36 0.06 
2,3,4,6,7,8-HxCDF 1.46 0.38 1.38 0.46 0.82 0.18 0.47 0.12 
1,2,3,7,8,9-HxCDF 1.38 0.27 1.20 0.23 <0.10  <0.10  
1,2,3,4,6,7,8-HpCDF 0.37 0.06 0.33 0.08 1.87 0.30 0.82 0.22 
1,2,3,4,7,8,9-HpCDF 0.33 0.06 0.30 0.05 <0.25  <0.25  
OCDF <0.50  0.87 0.48 0.62 0.10 <0.5  
2.3.7.8-TCDD 1.21 0.22 1.15 0.24 0.11 0.03 0.08 0.01 
1.2.3.7.8-PeCDD 2.58 0.50 2.30 0.49 0.32 0.04 0.14 0.05 
1.2.3.4.7.8-HxCDD 1.76 0.16 1.70 0.41 0.37 0.07 0.17 0.03 
1.2.3.6.7.8-HxCDD 1.65 0.39 1.46 0.32 1.65 0.23 0.44 0.10 
1.2.3.7.8.9-HxCDD 1.25 0.25 1.12 0.26 0.49 0.07 0.21 0.03 
1.2.3.4.6.7.8-HpCDD 0.47 0.08 0.40 0.09 3.02 0.45 0.90 0.21 
OCDD 1.37 0.45 1.09 0.14 3.32 0.36 1.76 0.35 
Total level  [ub] 6.21 1.05 5.68 1.07 1.48 0.13 0.88 0.15 
non-ortho PCBs   
PCB 81 46.8 6.3 42.3 8.3 0.7 0.1 0.54 0.15 
PCB 77 94.6 11.7 87.0 15.7 8.9 1.0 6.13 0.58 
PCB 126 41.4 7.0 37.6 7.4 3.4 0.5 2.27 0.67 
PCB 169 29.8 6.3 26.9 6.6 0.6 0.1 0.44 0.14 
Total levels [ub] 4.45 0.76 4.04 0.81 0.32 0.05 0.23 0.07 
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 feed E feed E + 10% sand feed A with 10% soil A feed A with 10% soil B 
Day  mean SD mean SD mean SD mean SD 
mono-ortho PCBs   
PCB 123 79 14 61 18 371 96 228  
PCB 118 15040 2682 13040 2490 <10  263 84 
PCB 114 64 19 54 12 124 30 <10  
PCB 105 8620 1308 7372 1318 37 8 69 35 
PCB 167 107 15 100 26 97 19 31 18 
PCB 156 1112 218 979 229 14 2 60 14 
PCB 157 89 19 88 20 16 2 11  
PCB 189 47 10 43 12 371 96 <10  
Total level [ub] 3.01 0.53 2.60 0.52 0.10 0.02 0.08 0.02 
   
Sum [ub] 13.67 2.32 12.32 2.39 1.91 0.20 1.19 0.23 
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Appendix 9. Levels of dioxins, non-ortho and mono-ortho PCBs in eggs from hens kept at the two 
farms where the soil was sampled in 2002, and which had been sampled previously in 2001. Individual 
levels expressed in pg/g fat (dioxins. non-ortho PCBs) and ng/g fat (mono-ortho PCBs). Total levels 
expressed as pg TEQ/g fat. 
 
 Eggs farm A Eggs farm B 
 2001 2002 2001 2002 
dioxins  
2,3,7,8-TCDF 2.84 2.3 0.63 0.72 
1,2,3,7,8-PeCDF 2.46 2.3 0.28 0.54 
2,3,4,7,8-PeCDF 3.56 3.1 0.44 0.66 
1,2,3,4,7,8-HxCDF 3.78 3.5 0.35 0.52 
1,2,3,6,7,8-HxCDF 2.88 2.8 0.26 0.40 
2,3,4,6,7,8-HxCDF 3.98 3.8 0.36 0.43 
1,2,3,7,8,9-HxCDF 0.15 0.16 < 0.10 < 0.10 
1,2,3,4,6,7,8-HpCDF 27.7 21.6 1.58 1.2 
1,2,3,4,7,8,9-HpCDF 0.62 0.54 < 0.25 < 0.25 
OCDF 6.62 4.9 0.68 < 0.50 
2.3.7.8-TCDD 0.55 0.34 0.07 0.09 
1.2.3.7.8-PeCDD 2.00 1.9 0.12 0.31 
1.2.3.4.7.8-HxCDD 2.64 2.6 0.16 0.28 
1.2.3.6.7.8-HxCDD 11.5 10 0.39 0.64 
1.2.3.7.8.9-HxCDD 3.15 3.1 0.20 0.27 
1.2.3.4.6.7.8-HpCDD 40.9 37 2.19 1.9 
OCDD 74.5 54 8.51 3.8 
Total level  [ub] 8.25 7.29 0.70 1.13 
non-ortho PCBs  
PCB 81 1.73 < 0.05 1.18 8.7 
PCB 77 21.7 28 16.1 148 
PCB 126 15.9 16 44.6 13 
PCB 169 2.82 3.0 6.24 2.7 
Total levels [ub] 1.62 1.63 4.53 1.37 
mono-ortho PCBs  
PCB 123 0.02 0.02 <0.01 0.03 
PCB 118 1.09 1.1 0.85 1.2 
PCB 114 0.01 0.01 <0.01 0.04 
PCB 105 0.31 0.36 0.16 0.52 
PCB 167 0.24 0.20 0.28 0.12 
PCB 156 0.44 0.38 0.43 0.19 
PCB 157 0.07 0.06 0.07 0.03 
PCB 189 0.07 0.06 0.07 0.05 
Total level [ub] 0.41 0.38 0.36 0.31 
  
Sum [ub] 9.87 9.31 5.22 2.81 
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Appendix 10. Levels of dioxins, non-ortho and mono-ortho PCBs in the different feeds used in study C. Results are expressed as the mean of 3 to 5 analyses, 
with the standard deviation and the variation coefficient. Individual levels in ng/kg. Total levels expressed in ng TEQ/kg. 
 
 feed E Exal H MycoAd Z Humac Klinofeed 
 mean SD %CV mean SD %CV mean SD %CV mean SD %CV mean SD %CV 
Dioxins                
2,3,7,8-TCDF 0.11 0.01 4 0.11 0.01 8 0.11 0.00 4 0.11 0.01 9 0.11 0.01 10 
1,2,3,7,8-PeCDF 0.24 0.02 7 0.29 0.00 1 0.29 0.01 3 0.30 0.01 2 0.28 0.01 4 
2,3,4,7,8-PeCDF 0.26 0.01 3 0.28 0.01 2 0.30 0.01 4 0.29 0.01 3 0.28 0.01 2 
1,2,3,4,7,8-HxCDF 0.29 0.01 5 0.32 0.01 4 0.33 0.02 5 0.31 0.01 3 0.31 0.01 4 
1,2,3,6,7,8-HxCDF 0.26 0.01 4 0.29 0.01 3 0.30 0.01 4 0.29 0.01 2 0.28 0.01 3 
2,3,4,6,7,8-HxCDF 0.22 0.05 20 0.33 0.01 2 0.33 0.01 4 0.31 0.01 5 0.30 0.01 2 
1,2,3,7,8,9-HxCDF 0.24 0.02 10 0.30 0.00 1 0.30 0.01 3 0.29 0.02 6 0.29 0.01 3 
1,2,3,4,6,7,8-HpCDF 0.99 0.48 49 0.39 0.02 4 0.39 0.01 3 0.38 0.01 2 0.38 0.01 4 
1,2,3,4,7,8,9-HpCDF <0.25   <0.25    <0.25    <0.25    <0.25    
OCDF 1.04 0.30 29 0.62 0.07 11 0.63 0.05 8 0.58 0.02 3 0.57 0.02 3 
2,3,7,8-TCDD 0.10 0.01 9 0.13 0.00 3 0.13 0.01 5 0.12 0.01 8 0.13 0.02 14 
1,2,3,7,8-PeCDD 0.26 0.02 9 0.35 0.03 8 0.38 0.05 13 0.32 0.02 7 0.32 0.01 3 
1,2,3,4,7,8-HxCDD 0.29 0.02 6 0.35 0.01 3 0.36 0.02 4 0.36 0.01 4 0.35 0.01 4 
1,2,3,6,7,8-HxCDD 0.29 0.03 11 0.29 0.01 3 0.30 0.02 5 0.29 0.01 3 0.29 0.01 3 
1,2,3,7,8,9-HxCDD 0.30 0.02 6 0.33 0.01 2 0.34 0.01 4 0.33 0.01 2 0.34 0.01 4 
1,2,3,4,6,7,8-HpCDD 1.07 0.57 54 0.42 0.07 17 0.40 0.02 5 0.39 0.01 3 0.38 0.02 5 
OCDD 5.62 3.86 69 1.76 1.28 73 1.19 0.09 7 1.20 0.15 12 1.14 0.14 13 
Total level  [ub] 0.73 0.03 5 0.87 0.03 4 0.93 0.06 7 0.84 0.04 5 0.84 0.03 4 
non-ortho-PCBs                
PCB 81 3.85 0.43 11 4.79 0.13 3 4.96 0.11 2 4.87 0.09 2 4.62 0.07 1 
PCB 77 8.62 0.80 9 10.49 0.34 3 11.00 0.29 3 11.36 0.21 2 10.36 0.11 1 
PCB 126 3.88 0.35 9 4.78 0.10 2 4.94 0.16 3 4.81 0.10 2 4.67 0.11 2 
PCB 169 3.71 0.36 10 4.76 0.09 2 4.89 0.17 3 4.63 0.15 3 4.53 0.10 2 
Total level [ub] 0.43 0.04 9 0.53 0.01 2 0.55 0.02 3 0.53 0.01 2 0.51 0.01 2 
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 feed E Exal H MycoAd Z Humac Klinofeed 
 mean SD %CV mean SD %CV mean SD %CV mean SD %CV mean SD %CV 
mono-ortho PCBs                
PCB 123 <0.01   <0.01    <0.01    <0.01    <0.01    
PCB 118 1.29 0.12 9 1.57 0.04 3 1.62 0.06 3 1.63 0.02 1 1.58 0.06 4 
PCB 114 <0.01   <0.01    <0.01    <0.01    <0.01    
PCB 105 0.72 0.07 10 0.89 0.02 2 0.91 0.03 3 0.92 0.01 1 0.90 0.03 3 
PCB 167 <0.01   0.01 0.00 1 0.01 0.00 3 0.01 0.00 1 0.02 0.01 63 
PCB 156 0.12 0.01 8 0.14 0.00 2 0.15 0.01 3 0.15 0.00 1 0.15 0.01 9 
PCB 157 0.01 0.00 2 0.01 0.00 5 0.01 0.00 5 0.01 0.00 5 0.02 0.01 65 
PCB 189 <0.01   <0.01    <0.01    <0.01    <0.01    
Total level [ub] 0.27 0.02 9 0.33 0.01 2 0.34 0.01 3 0.34 0.00 1 0.34 0.02 6 
                    
Som [ub] 1.42 0.09 7 1.73 0.04 2 1.81 0.08 5 1.71 0.05 3 1.70 0.05 3 
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Appendix 11. Levels of dioxins, non-ortho and mono-ortho PCBs in eggs (day14,32)and abdominal fat from hens fed with feed E containing 4 different 
binders. Individual levels expressed in pg/g fat (dioxins. non-ortho PCBs) and ng/g fat (mono-ortho PCBs). Total levels expressed as pg TEQ/g fat. 
 
 feed E Exal H MycoAd Z Humac Klinofeed 
Day 14 32 fat 14 32 fat 14 32 fat 14 32 fat 14 32 fat
dioxins      
2,3,7,8-TCDF 1.02 1.02 1.13 0.74 1.08 1.20 0.64 0.98 1.08 0.84 1.19 1.22 0.66 * 0.98
1,2,3,7,8-PeCDF 2.40 2.63 2.31 * 2.57 2.27 1.44 * 1.92 1.95 * 2.42 * 2.44 1.66
2,3,4,7,8-PeCDF 2.38 2.41 2.36 1.75 2.65 2.23 1.42 2.26 2.06 1.81 3.07 2.46 1.76 2.40 1.87
1,2,3,4,7,8-HxCDF 3.13 2.84 1.46 2.26 2.70 1.39 1.86 2.34 1.21 2.56 3.10 1.57 2.21 2.50 1.13
1,2,3,6,7,8-HxCDF 2.89 2.66 1.36 2.03 2.43 1.16 1.72 2.05 1.02 2.22 2.90 1.30 1.93 2.23 0.94
2,3,4,6,7,8-HxCDF 2.71 3.22 1.46 2.58 1.99 0.99 1.20 2.72 0.84 2.70 3.42 0.93 2.44 2.64 0.84
1,2,3,7,8,9-HxCDF 2.51 2.48 1.38 1.85 2.30 1.26 1.37 1.72 0.93 1.98 2.73 1.40 1.73 2.12 1.05
1,2,3,4,6,7,8-HpCDF 1.74 1.46 0.37 1.33 1.41 0.34 * 1.10 0.28 1.54 1.71 0.29 1.22 1.22 0.29
1,2,3,4,7,8,9-HpCDF 1.51 1.22 0.33 1.09 1.19 0.35 0.85 0.94 0.31 1.34 1.35 0.35 1.02 1.01 0.27
OCDF 1.08 0.75 <0.50 0.77 0.80 <0.50 0.66 0.67 <0.50 0.89 0.96 <0.50 0.72 0.74 <0.50
2.3.7.8-TCDD 0.76 0.94 1.21 0.58 1.01 1.10 0.52 0.86 1.06 0.65 1.22 1.32 0.52 0.94 0.92
1.2.3.7.8-PeCDD 2.69 2.99 2.58 1.97 2.97 2.36 1.59 2.46 2.26 2.02 3.32 2.73 1.77 2.76 1.98
1.2.3.4.7.8-HxCDD 3.56 3.36 1.76 2.48 3.14 1.81 2.33 2.77 1.71 2.82 3.64 2.09 2.44 2.90 1.42
1.2.3.6.7.8-HxCDD 3.07 3.10 1.65 2.28 2.73 1.55 2.07 2.50 1.43 2.52 3.39 1.67 2.15 2.69 1.25
1.2.3.7.8.9-HxCDD 2.85 2.59 1.25 1.98 2.47 1.22 1.59 1.91 1.01 2.27 2.91 1.35 2.00 2.29 0.97
1.2.3.4.6.7.8-HpCDD 2.25 1.95 0.47 1.79 1.75 0.44 1.39 1.63 0.43 2.07 2.22 0.47 1.60 1.75 0.39
OCDD 4.89 4.18 1.37 3.65 3.70 0.87 3.04 4.28 1.26 4.50 4.96 0.79 3.62 3.56 0.77
Total level  [ub] 6.99 7.44 6.21 5.10 7.36 5.71 4.20 6.19 5.37 5.51 8.46 6.53 4.77 6.81 4.75
non-ortho PCBs      
PCB 81 27.2 40.3 46.8 21.3 38.5 41.7 17.6 34.9 39.3 22.0 44.9 48.4 18.3 33.5 34.8
PCB 77 69.5 95.2 94.6 60.6 94.8 85.2 47.2 92.5 82.0 62.5 109.0 99.2 49.4 82.3 73.2
PCB 126 37.8 47.4 41.4 26.7 42.3 39.7 23.8 38.9 36.8 29.0 48.9 44.5 24.8 38.5 31.6
PCB 169 51.7 50.8 29.8 35.4 45.2 28.6 31.6 41.7 26.2 40.2 55.6 32.2 35.4 44.0 22.7
Total levels [ub] 4.31 5.26 4.45 3.03 4.70 4.27 2.70 4.32 3.96 3.31 5.46 4.79 2.84 4.30 3.40
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 feed E Exal H MycoAd Z Humac Klinofeed 
Day 14 32 fat 14 32 fat 14 32 fat 14 32 fat 14 32 fat
mono-ortho PCBs      
PCB 123 0.07 0.08 0.08 0.05 0.08 0.07 0.04 0.07 0.07 0.06 0.09 0.08 0.05 0.07 0.06
PCB 118 12.00 14.70 15.04 8.50 13.90 14.18 7.36 12.00 12.73 9.06 15.90 15.82 7.52 11.90 11.39
PCB 114 0.05 0.06 0.06 0.04 0.06 0.06 0.04 0.05 0.05 0.04 0.07 0.07 0.03 0.05 0.05
PCB 105 6.24 8.14 8.62 4.46 7.67 8.14 3.85 6.53 7.21 4.77 8.69 9.05 3.89 6.52 6.48
PCB 167 0.16 0.15 0.11 0.12 0.14 0.11 0.10 0.12 0.10 0.13 0.16 0.12 0.11 0.13 0.09
PCB 156 1.40 1.48 1.11 0.99 1.34 1.11 0.88 1.21 0.98 1.09 1.59 1.16 0.91 1.22 0.83
PCB 157 0.12 0.12 0.09 0.08 0.11 0.09 0.08 0.11 0.08 0.10 0.14 0.10 0.09 0.11 0.07
PCB 189 0.13 0.12 0.05 0.09 0.11 0.05 0.09 0.10 0.05 0.10 0.13 0.05 0.09 0.10 0.04
Total level [ub] 2.63 3.14 3.01 1.87 2.93 2.87 1.63 2.55 2.56 2.01 3.38 3.17 1.67 2.55 2.27
    
Sum [ub] 13.93 15.84 13.67 10.00 14.99 12.86 8.53 13.06 11.89 10.83 17.30 14.48 9.28 13.66 10.42
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Appendix 12. Levels of indicator-PCBs in eggs (day 14,32) and abdominal fat from hens fed with feed 750 containing 4 different binders. Individual levels 
expressed in ng/g fat  
 
 feed E sand Exal H MycoAd Z Humac Klinofeed 
Day 14 32 fat 14 32 fat 14 32 fat 14 32 fat 14 32 fat
      
PCB 28 3.8 7.8 9.2 3.9 7.9 9.5 3.4 6.8 8.7 4.4 8.8 8.7 3.4 6.6 7.8
PCB 52 1.9 2.1 2.4 1.6 1.7 1.8 1.5 1.5 1.8 2.1 2.1 2.6 1.4 1.5 1.6
PCB 101 4.8 5.9 5.2 4.3 4.5 4.2 4.3 4.5 4.3 5.2 5.6 7.0 3.7 4.1 3.7
PCB 118 8.0 13.2 11.8 8.0 13.0 12.5 7.2 11.0 11.3 8.9 14.5 16.6 7.3 11.3 10.1
PCB 138 20.3 30.1 23.5 19.4 28.4 25.3 18.1 25.1 23.0 23.1 32.9 26.8 18.9 26.0 20.1
PCB 153 22.5 32.4 21.9 21.6 30.1 23.9 20.0 26.2 21.5 24.4 34.5 22.7 20.8 27.6 18.7
PCB 180 20.7 25.6 10.0 19.3 23.4 11.6 18.4 21.4 10.1 22.8 27.5 11.9 19.4 22.6 8.8
Total level  [ub] 82.0 117.1 83.9 78.0 109.0 88.7 73.0 96.5 80.6 90.7 125.9 95.6 74.8 99.7 70.8
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Appendix 13. Carry-over rates of the different dioxin and PCB congeners as determined at day 42 for 
the two feeds containing the highest levels 
 
 feed E feed F 
   
Dioxins   
2,3,7,8-TCDF 40 40 
1,2,3,7,8-PeCDF 39 48 
2,3,4,7,8-PeCDF 38 44 
1,2,3,4,7,8-HxCDF 43 44 
1,2,3,6,7,8-HxCDF 40 42 
2,3,4,6,7,8-HxCDF 31 35 
1,2,3,7,8,9-HxCDF 39 41 
1,2,3,4,6,7,8-HpCDF 18 18 
1,2,3,4,7,8,9-HpCDF 20 21 
OCDF 7 5 
2,3,7,8-TCDD 41 47 
1,2,3,7,8-PeCDD 41 45 
1,2,3,4,7,8-HxCDD 42 44 
1,2,3,6,7,8-HxCDD 44 44 
1,2,3,7,8,9-HxCDD 32 34 
1,2,3,4,6,7,8-HpCDD 22 21 
OCDD 13 8 
non-ortho-PCBs   
PCB 81 40 41 
PCB 77 45 50 
PCB 126 48 50 
PCB 169 50 52 
mono-ortho PCBs   
PCB 123 78 70 
PCB 118 48 52 
PCB 114 52 51 
PCB 105 46 52 
PCB 167 84 76 
PCB 156 55 58 
PCB 157 51 65 
PCB 189 61 61 
Indicator-PCBs   
PCB 28 38 43 
PCB 52 5 4 
PCB 101 5 5 
PCB 118 47 55 
PCB 138 51 54 
PCB 153 57 61 
PCB 180 59 41 
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Appendix 14 Technical information Mathematical model development 
 
The kinetics of dioxin-like substances in eggs contains three main aspects: absorption of the ingested 
contaminants over the gut wall, distribution of the contaminants over the different tissues and 
developing yolks, and elimination from the body by eggs and liver metabolism. Each different congener 
may have its own characteristic properties, such as its fraction absorbed, its tissue:blood partition 
coefficients, its metabolic clearance and its transfer from blood to the developing yolks. This may well 
implicate that each congener has its own typical kinetics which would force a different parameterisation 
of the model parameters for each different congener. In a first approach it was tried to model the mix of 
administrated congeners by considering the mix as if one substance only, quantitatively represented by 
its amount of total Toxic EQuivalents (TEQs). 
 
Absorption 
Because of the high lipophilicity of the dioxin-like substances (PCDDs, PCDFs and PCBs), it may be 
assumed that in the gut they are mainly dissolved in the lipid fraction of food. Consequently, the 
absorption of the contaminants over the gut wall is correlated to the efficiency of lipid uptake. As the 
hens lay eggs with a mean fat weight of 6 (g/egg) and with an efficiency of about 85%, the daily loss of 
fat of a hen is 5.1 (g/day). From the experiments, it appears that the mean hens food intake was 116 
(g/day) with a feed lipid fraction that was estimated to range from 3 to 5%, which amounts to a lipid 
intake in the range of about 3.5-5.8 (g/day). Thus, lipid absorption, and so absorption of ingested 
contaminants, is expected to be efficient and to range from 90 to 100%.  
 Pirard and De Pauw (2002) found absorption percentages for PCDDs and PCDFs in a range from 
90-100% for log Kow values up to 7.8, with an exception for a number of PCDFs in the log Kow range 
of 7.1-7.8. For still higher log Kow values, absorption declined to about 30%. However, these high 
chlorinated congeners tend to have Toxic Equivalent Factors (TEFs) ranging from 0.01 to 0.0001, so 
they do not substantially contribute to the total of administrated TEQs. For non-ortho PCBs Pirard and 
De Pauw found absorption percentages up to 96%, independent of the degree of chlorination. 
 
Distribution 
Partition of the contaminants between different tissues is determined by solution of the contaminants in 
the tissues lipid fraction and by binding to tissue proteins, mainly to (plasma) albumin. In the liver 
dioxins can possibly bind additionally to specific liver enzymes. Because of the lipid solubility, partition 
is determined by the tissues lipid content and the tissues lipid composition, i.e., the subdivision of the 
lipid fraction in phospholipids and neutral lipids (Poulin and Krishnan, 1995a, 1995b). 
The neutral lipid content of adipose tissue is almost 100% in every mammal (ibid.), while in rats blood 
lipid is composed of 51% of phospholipids and 49% of neutral lipids, liver lipid is composed of 42% of 
phospholipids and 58% of neutral lipids, and muscle of 54% of phospholipids and 46% of neutral lipids 
(Poulin and Krishnan, 1995a). In humans, these percentages are 32% and 68% for blood, 42% and 58% 
for liver and 23% and 77% for muscle, respectively. So, the interspecies differences can be considerable. 
 Germs (1985) found lipid contents of a number of tissues but did not consider the composition of 
the lipid fraction of tissues. Based on these data, only crude approximations to the tissue:blood partition 
coefficients can be made. E.g., the lipid content of blood is about 1%. When 51% consists of 
phospholipids, like in rats, then the adipose tissue:blood partition coefficient is about 150, when 32% 
consists of phospholipids, like in humans, the partition coefficient is about 120, while when all blood 
lipid would be neutral lipid, then the partition would be 95. These estimations are obtained by assuming 
that also in hens adipose tissue consists of about 100% of neutral lipids. 
 RIKILT Rapportnummer 2004.016  
 Likewise, ranges for partition coefficients in other tissues can be found. Generally, from PBPK 
models it is found that partition coefficients of dioxin like substances for tissues other than adipose 
tissue range from about 5-10% of the partition coefficient for adipose tissue. However, in rats liver 
enzymes are induced which not only causes augmented metabolism rate, but also a considerable 
additional binding storage such that the liver:blood partition exceeds the adipose tissue:blood partition 
by several factors (Abraham et al., 1988; Zeilmaker and van Eijkeren, 1997, Zeilmaker et al., 1999). In 
cattle, also such a phenomenon is noticed but not to such an extreme level (Thomas et al., 1999). 
 The only way different congeners may possess substantially different tissue:blood partition 
coefficients is by their chemical property of binding to proteins. If such binding is negligible, the 
partition coefficient values based on lipid content and lipid composition only would be almost the same 
for all congeners. 
 
Metabolism 
Elimination by metabolism mainly takes place in the liver. Metabolism may be enhanced by induction 
of metabolising enzymes, just like binding storage capacity. In rats induction of enzymes takes place to 
such extend that both metabolism rate and storage capacity are augmented considerably (Abraham, 
1988; Zeilmaker and van Eijkeren, 1997, Zeilmaker et al., 1999). In cattle, such an extreme induction 
effect is not noticed. In lactating subjects, excretion via milk fat dominates elimination by metabolism. 
In a first approach, it will be assumed that, likewise, in laying hens elimination by metabolism is 
dominated by excretion via egg yolk fat. 
 
Excretion 
In a series of papers by Donoghue and co-workers (Donoghue et al. 1996,1997a , 1997b, 1999, 2000, 
2001) investigate residue uptake by eggs of different drugs and the pesticide lindane. They clearly 
distinct the uptake by the developing yolks and by egg albumin. The former takes place during the 
development of the yolks during several days, while the latter takes place when the ovulated yolk is 
surrounded by the egg white in the oviduct. Because of the high lipophilicity of the contaminants, it is 
assumed that from the start of egg white formation there is no further transport of contaminants from 
blood to the egg yolk, while the contamination of egg white is considered to be negligible. 
 Donoghue and co-workers showed a high correlation between uptake of a single administration of 
drug into egg yolks and the egg yolks growth phase. Based on these observations they developed a 
model to predict the pattern of residues, i.e., relative levels, after a number of days of administration, but 
not to predict the absolute residue levels themselves (Donoghue et al. 1996, 1997b, 2001). From these 
results it is assumed that uptake of contaminants in the developing yolks is proportional to the product 
of the contaminant concentration in blood and the daily growth rate of each yolk. Moreover, based on an 
experiment with magnevist (Donoghue and Meyers, 2000), it was assumed that incorporation of the 
contaminant in egg yolk is irreversible. This approach needs information about yolk development. 
 
Yolk development and egg yolk excretion model 
Gilbert (1972) presents data on ovum weight from about 8 days before ovulation to 1 day before. 
Donoghue et al. (1996) present data on daily change in yolk weight. Based on these data, a model was 
chosen that allowed for virtually no yolk development until 10 days before ovulation, maximum growth 
about 3 days before ovulation and symmetry of development during the periods before and after the 
time of maximum growth. Taking the time of ovulation, for reason to follow denoted by s instead of t, as 
0s = , the model used is 
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  12( ) ( ) (tanh( ( )) 1)min max minw s w w w sω τ= + − − +&  (1) 
 
Here, minw  is the weight of the smallest yolks, maxw  is a virtual yolk weight that would be attained if 
yolk development was not stopped by ovulation and ω&  determines both maximum growth rate and the 
time interval during with growth is essentially non zero, say from ten days before ovulation until 
ovulation. Note, that at the time of ovulation, yolk weight is 
 
  10 2(0) ( ) (tanh( ) 1)min max minw w w w w ω τ= = + − ⋅ +&  (2) 
 
A slight complication enters the yolk development model by the definition of zero time being time of 
ovulation: every yolk has its own time of ovulation and consequently its own subjective time. Another, 
objective, time measures time evolution during the experiment. If the start of the experiment is taken to 
be the objective time 0t = , then a yolk that will be ovulated at time s has as its growth curve 
 
  12( , ) ( ) ( ) (tanh( ( )) 1)min max minw t s w t s w w w t sω τ= − = + − + − +&  (3) 
 
Using the data in Gilbert (1972) and Donoghue et al. (1996) and estimating the egg yolk volume to be 
1/3 of the egg weight (Kans Yellow Rule, Kan, 2002), the parameterisation of the model in equation (3) 
is 
 
  0.09 (g); 20.0 (g); 0.5 (-/day); 3.3 (day)min maxw w ω τ= = = =&  (4) 
 
This parameterisation resulted in a egg yolk weight of 0 18.1 (g)w = . 
So, in the laying hen model, an array of developing yolks is modelled: time s is discrete because of the 
discrete time points of ovulation and to each position in the array a corresponding time of ovulation is 
associated. When the objective time has surpassed the time of ovulation of a yolk, its corresponding 
array position is ignored in the progressing calculations, otherwise it will still develop following 
equation (3) and contribute to the excretion by adding a term 
 
  
excretion to
i-th follikel
( ) ( ) ( )b i b
dA t w t s C t
dt
γ  = − −   &  (5) 
 
where ( )bA t  and ( )bC t  denote the amount and concentration of TEQs in blood at time t, ( )iw t s−&  is 
the growth rate at time t of yolk i, to be ovulated at time is  and γ  is a factor determining the efficiency 
of transfer of the contaminants from blood the yolks. 
 
Laying hen physiological model 
Following the standard Physiologically Based PharmacoKinetic (PBPK) modelling approach, the laying 
hen was subdivided in five compartments: blood (for transport), fat (for storage of the highly lipophilic 
contaminants), liver (for metabolism) and the remainder subdivided in slowly and richly perfused 
tissues. This compartimentation was based on the laying hens body composition as reported by Germs 
(1985) and Uijttenboogaart (1985). Although the model provided a reasonably fair description of the 
experimental data, there is a great number of unknown or only poorly known parameters, such as 
compartmental blood flows, tissue:blood compartment partition coefficients, liver specific intrinsic 
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clearance and the efficiency of contaminant incorporation into egg yolk. Fitting all these parameters is 
not sensible, and fitting only a subset yields results that explicitly depend on the values attributed to the 
parameters of the other subset that is not fitted. Sensitivity analysis of the individual parameters is not 
always helpful when varying sensitive parameters which are correlated. 
 As a consequence, it was decided to reduce the number of compartments. Sensible lumping of 
compartments highly depends on the kinetics of the substance of interest. In the case of lipophilic 
contaminants, the fat compartment not only serves as a high storage distribution volume but also, 
because of its relative poor blood perfusion, as a compartment with a relative long characteristic time of 
contaminant concentration equilibration with the blood compartment. From PBPK models for TCDD in 
rats, cattle and humans, it appears that these times are at least an order of magnitude longer then the next 
characteristic times for equilibration of blood with slowly perfused tissue. For hydrophilic drugs, e.g., 
this can be quite different. 
 These considerations lead to the decision to model two compartments only: the adipose tissue 
compartment and the rest of the body. The blood concentration, necessary to determine excretion of the 
contaminants by eggs, is determined by the distribution volume of the rest compartment 
 
  D r r c c
compartments
V PV PV= = ∑  (6) 
 
determined by the sum of the distribution volumes of the other compartments. This model implies that 
the contaminant concentrations of all the tissues contained in the rest compartment are in instantaneous 
equilibrium. This alternative compartmentation is corroborated by considerations of parameter 
identification as will be shown in the next section: the data available do not allow for a more refined 
compartmentation when corresponding introduced parameters are unknown. 
 
Mathematical model formulation 
Physiologically based model 
The kinetics of dioxin-TEQs in laying hens is modelled by the next mass balances 
 
  
( / / ) / ( ) /
( / / )
( ) /
r
f r r f f l r r i r r abs
i
f
f r r f f
i
i r r
dA Q C P C P CL C P w t s C P F D
dt
dA
Q C P C P
dt
dA w t s C P
dt
γ
γ
= − − − − − +
= −
= −
∑ &&
&
 (7) 
 
The first line shows the rate of change of the amount of TEQs in the rest compartment (left hand side) 
because of loss to (or gain from) the fat compartment (first term right hand side), loss by metabolic 
clearance in the liver (second term r.h.s), residue excretion to the developing yolks (third term r.h.s) and 
because of gain by absorption of the daily dose of contaminants over the gut wall (fourth term r.h.s). 
The second line shows the rate of change of the amount of TEQs in the fat compartment (l.h.s) because 
of gain from (or loss to) the rest compartment (r.h.s). The last line shows the incorporation of the 
contaminants in the yolks. The concentrations in equation (7) are derived by dividing the amounts by 
the corresponding compartment volumes. 
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Classical compartmental model 
The model in equation (7) can be reformulated in terms of the amounts of contaminant in the 
compartments only. When the following quantities 
 
  , , ,f f lr f
r r f f r r r r
Q Q CLq q k Y
PV P V PV PV
γ= = = =  (8) 
 
are defined, then equation (8) can be reformulated as: 
 
  
( )
( )
r
r i r f f abs
i
f
r r f f
i
i r
dA q k Yw t s A q A F D
dt
dA
q A q A
dt
dA Yw t s A
dt
 = − + + − + +  
= −
= −
∑ &&
&
 (9) 
 
Note that the daily dose in equation (7) and (9) is just the mean contaminant intake per day, i.e., the 
actual intake at any moment of the day integrated over one day (and divided by 1 (one day)). Likewise, 
one could integrate the growth over one day. Summing that result over all the yolks, one arrives at the 
total yolk growth per day 
 
  
0
0( ) ( ) min
t
w t s ds w d w wσ σ
∞
−∞
− = = −∫ ∫& &  (10) 
 
and a new parameter 
 
     0( )miny Y w w= −      (11) 
 
is defined accordingly. Note that sometimes equation (1) is interpreted as a weight, and sometimes as a 
weight per day. The latter assume division by 1 (one day). This is the usual confusion introduced when 
multiplying or dividing by one unit. 
 Proceeding this way, the first line in equation (9) can be reformulated as 
 
  ( )r r r f f absdA q k y A q A F Ddt = − + + + + &  (12) 
 
The first two lines in equation (9) constitute an autonomous system of equations, that can be solved 
independently of the third line. Though these equations were derived from the physiological model in 
equation (7), they provide a possible explanation of the data even without this physiological 
interpretation. Then the equations just state that the amount of contaminants administered redistributes 
over the hens body by contaminant transfer between two compartments and contaminant loss by two 
routes of elimination of which one is excretion by egg yolk. Such kind of modelling is the typical 
classical compartmental modelling approach. The classical model of equation (9) and (12), can easily be 
solved and analysed for parameter identification. 
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Classical kinetic model 
Assuming that initially there is no contamination with dioxins at all, the analytical solution to the first 
two lines of equation (9) is 
 
   
2 1
2 1
1 2
1 2
1 2
1 2
( ) ( )( ) 1
( ) 1
t t
abs
r
t t
absr
f
f
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where the exponential rates are given by 
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A purely descriptive analogue of equation (13) would be 
 
   
( )
( )
2 1
2 1
, ,2 ,1
, ,2 ,1
( ) 1
( ) 1
t t
r r r r
t t
f f f f
A t A a e a e
A t A a e a e
λ λ
λ λ
∞
∞
= ⋅ − −
= ⋅ − −      (15) 
 
which is the typical kind of approach in classical kinetic modelling. Note that this approach can be 
fruitfully applied for data interpolation even without the classical compartmental modelling 
interpretation. Nevertheless, if initial amounts are to be zero, then one should be aware that 
,1 ,2 ,1 ,2 1r r f fa a a a+ = + = . Moreover, if the classical kinetic model is to be interpreted in terms of 
classical compartmental modelling, the exponential coefficients for the fat compartment cannot be 
chosen freely at all: they should be the coefficients in equation (13). 
Compartmental system identification analysis 
Identification of model parameters by fitting them to experimental data can only be successful when the 
experimental set-up is devised as to allow for that purpose, i.e., it depends on how and where the forcing 
is applied (e.g., intravenous or subcutaneous or inhalatory or oral or whatsoever combination of these, 
bolus injection, discontinuous infusion or continuous administration) and what is sampled (e.g., 
concentration in blood, fat, egg yolk or whatsoever). 
 These experiments concern the research of egg contamination as a result of oral intake of 
environmental contaminants, so, the forcing is established as is the monitoring of  egg yolk 
contamination. Moreover, the choice was made to sample abdominal fat. This choice was made in order 
to check the quite interesting phenomenon that seems to be observed occasionally, that eggs have a 
greater concentration of this kind of contaminants per gram of egg yolk than adipose tissue per gram of 
fat. 
 If concentrations in abdominal adipose tissue are representative for the concentration in the fat 
compartment as defined in the physiological model, which compartment includes (sub)-cutaneous fat, 
inter-muscular fat and bone marrow fat at least, then, in terms of the model, the sampled concentrations 
can be described by ( ) /f fA t V . The egg yolk concentrations in the model, do not precisely represent 
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( )rA t , but a weighted integral of this quantity over the past. The weights are the product of the 
contaminant incorporation efficiency and the daily yolk growth rates which are known. However, for 
simplicity of identification analysis, it will be assumed that the egg ovulated at time t just contains 
precisely the concentration ,( ) /r y fyA t V  TEQ per gram of egg yolk, instead of an integral over the past. 
,y fV  is the egg yolk volume. Actually, in the following it will be seen that this approach yields a far 
better description of the data. The volume of egg yolk is estimated to be 1/3 of the volume of egg yolk 
itself (Kans Yellow Rule once more). Under this assumption, the identification analysis proceeds as 
follows. From the analytical solution in equation (13), one can see that from the experimental set-up the 
following observable parameters can be estimated from the data: 
Terminal, slow, exponential rate 2λ  
Initial, fast, exponential rate 1λ  
Factor of the slow rate exponent 1 1 2( ) /( )y kλ λ λ+ + − , or, equivalently of the fast rate 
exponent 2 1 2( ) /( )y kλ λ λ+ + − . 
Maximum level of egg yolk fat concentration ,
/abs y fyF D V
y k+
&
 
Maximum level of adipose tissue concentration 
/abs fr
f
F D Vq
q y k+
&
 
 In the following, parameters or combinations of them, which are known or identified will get an 
asterisk as superscript. From the exponential rates, one identifies  from their sum (see equation (14) the 
sum * *1 2( )f rq q y k λ λ+ + + = − + , and from their product the product * *1 2( )fq y k λ λ+ = ⋅ .  
 From the third observable, one identifies the total elimination: 
( )** * *1 2 1 1 2 1( ) ( ) /( )y k y kλ λ λ λ λ λ+ = − + + − − . And so the parameter 
* * *
1 2 /( )fq y kλ λ= ⋅ +  i.e., the rate of transfer of contaminants from the fat compartment to the rest 
compartment is identified, while the reverse transfer rate * * * *1 2( ( ) )r fq q y kλ λ= − + + + +  is identified 
too. 
 All these expressions of compartmental model parameters contain the sum y k+  of both 
elimination rates, as does the fifth observable. The only way elimination by excretion or metabolism can 
be identified separately is by using the fourth observable. However, this observable contains the 
unknown absorption fraction absF . This parameter could be identified from the fifth observable, but that 
implies that the volume of what is considered as the fat compartment (and which may include, 
additional to abdominal fat and (sub) cutaneous, inter-muscular fat, fat contained in bone marrow and 
fat contained in feathers) must be known. Uncertainty in this parameter could well dominate the 
uncertainty in the absorption fraction for which there is a reasonable estimation that it lies between 90 
and 100%. 
 First, assume that the absorption of the contaminants is almost complete, i.e., 1absF = , then y can 
be identified from 
*
*
,
**
,
/ ( )
/
abs y f
y f
yF D V y ky
y k D V
  += ⋅  + 
&
&  Once this parameter is identified, the metabolism 
elimination rate can be identified too: * *( )k y k y= + − . Note that this way all the compartmental 
system parameters in equation (8) can be identified. The fifth observable parameter allows for the 
additional identification of the fat compartment volume:  
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 On the other hand, there are no data about the formation of metabolites and any value found for this 
parameter cannot be validated. So, as another extreme, assume that there is no elimination by 
metabolism at all, i.e., 0k = . This assumption leads to the determination of the absorbed fraction 
( )** *, ,/ /abs y f abs y fF V F D V D= & & . And again all the compartmental system parameters in equation (8) 
can be identified as well as the fat compartment volume. 
 Straightforward calculation shows that the values of the absorption fraction and the metabolism rate 
are related by 
 
  ( )
1*
*
1 1abs
abs
yF k
F y k y k
−     = ⋅ −     + +    
  (16) 
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As a conclusion of this analysis it can be stated that the experimental data are insufficient for a complete 
identification. Complete identification is only possible if the absorbed fraction can be estimated from 
sampling faeces, or if the metabolism rate can be determined, which requires the detection of the total of 
metabolites. The latter option seems to be prohibited by the enormous effort it would take analytically. 
Note, that it would not help at all if the concentration in blood ( /r rC P= ) was sampled additionally to 
the concentration in egg yolk: its analytical expression contains the sum y k+  only (see equation (7), 
/r r rC A V= ). So, if for instance the concentration in blood was sampled instead of the concentration in 
egg yolk, identification would not have been possible at all. 
 
Physiological model identification analysis 
Once the compartmental system parameters have been identified, one should consider whether this 
identification leads to identification of the physiological model parameters. Note that the compartmental 
model parameters depend on the physiological parameters as in equation (8). Depending on the choice 
1absF =  or 0k = , five other compartmental model parameters can be identified, so including the 
assumption on absorption or metabolism rate to the set of identified parameters, six model parameters 
are known.  
 Besides the fraction absorbed, the physiological model counts seven other unknown parameters: 
, , , , ,  and f r f l f rQ P P CL V Vγ . However, as the total body weight is known, the last parameter can be 
identified once the fat compartment volume has been identified, so, there remain only seven unknown 
parameters in the physiological model, one more than can be identified from the compartmental model. 
So, complete identification of the physiological model is never possible without additional knowledge 
of the value of one of its parameters , , ,  or f r f lQ P P CLγ . Once one of these parameter values is 
known, e.g., the regional fat compartment blood flow, the other ones can be derived from the 
compartmental model parameters. 
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Experimental data 
Laying hen body weights of 85 hens were measured with a mean of 1840 (g), population standard 
deviation of 260 (g) and a median of 1810 (g). 
 The hens abdominal fat was weighed and an estimation of the weight of the remaining abdominal 
fat was made. From these two data the total abdominal fat weight was estimated. There appeared to be a 
strong correlation between relative abdominal fat weight and body weight. The abdominal fat weight of 
a hen of 1840 (g) was estimated to be 86.5 (g). Uijttenboogaard (1985) reports a relative skin weight of 
laying hens of about 9% and Germs (1985) reports relative fat percentages of about 50%, which 
amounts to another 4.5% of relative fat weight, i.e., 82.8 (g). Another slowly perfused storage 
compartment is bone marrow, from data presented by Germs (1985) to be about 1.4% of body weight, 
i.e., 25.8 (g). Yet another storage compartment in this respect are the hens feathers with about 5% of 
body weight (Uijttenboogaard, 1985) and 4% of lipid content, i.e., another 4 grams contributing. All 
these contributions would amount to a total fat compartment volume of about 200 (g). 
 Weights of 76 eggs were measured with a mean weight of 54.4 (g), population standard deviation of 
1.7 (g) and median of 54.5 (g). Application of Kans Yellow Rule gives an estimate of egg yolk weight of 
18.2 (g) and application of the rule once more results in an estimated egg yolk fat weight of 6.1 (g). 
 The experimental data are the concentration in abdominal fat and the concentration in egg yolk fat 
of the congeners and the total concentration in TEQs. Note that from the identification analysis above it 
appears that the egg yolk data are, within the uncertainty with respect to the fraction absorbed and the 
metabolic clearance rate, sufficient for identification of the classical compartmental model parameters. 
The additional data on the concentration in abdominal fat will be used for an estimate of the fat 
compartment volume. 
 
Practical model identification: classical compartmental model 
The model, as described by the equation (9) together with the modification as described in equation (12) 
has been implemented in the versatile modelling package ACSL-model (Advanced Continuous 
Simulation Language; AEgis Technologies Group, Inc., Huntsville, AL, USA). The packages ACSL-
Math and ACSL-Optimize were used to fit the model parameters to all the egg yolk and abdominal fat 
data for all the five different dose levels simultaneously. The heteroscedasticity parameter of the error 
model was fitted too. When this parameter value is zero, errors are purely absolute, and when it has the 
value 2, errors are purely relative. Both for the data in egg yolk and fat, values in the vicinity of 1 were 
found. 
 Besides the parameters in the foregoing discussion, one more parameter was fitted. This parameter 
can be identified independently of the others and regards the following problem. At the start of the 
experiment, i.e., the time of first administration of contaminated feed, some of the hens have just 
ovulated, others will have their ovulation one hour later, etc. Eggs are collected and to avoid noise by 
inter-individual variation as much as possible, mixed yolks are analysed. In the model an off-set time is 
modelled, representing the mean (median) time between start of the experiment and time of first 
ovulation. Incidentally, the yolk ovulated at some time, is laid one day later. 
 One other slight complication is that not intentionally contaminated feed is still contaminated by 
background contamination. This contamination results in an initial background contamination of egg 
yolk and the hens tissues. Experimental data of background egg concentrations were available and an 
the estimated initial concentration in egg yolk is 0.52 pg TEQ/g egg yolk fat. Assuming that background 
contamination is steady state, the initial concentrations in the compartments could be estimated. 
 Although the model fits resulted in a reasonably fair description of the data (see figure 1), it was 
found that the egg yolk concentrations of the first days of sampling (notably day 2 and 5) were 
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systematically under estimated. As the concentration-time data show a clear bi-exponential behaviour, it 
was decided to try to model the data by the classical kinetic model. 
 
 
 
 
 
 
 
 
Figure 1. Classical compartmental model. 
Concentration in egg yolk (left panel) and 
abdominal fat (right panel). The lines show 
the calculated concentration-time curves, the 
symbols denote experimental data. Five 
contamination levels: 0.34 ng / kg feed 
(lower line, *), 0.58 ng / kg feed (next lower 
line, +), 0.76 ng / kg feed (middle line, x), 
1.85 ng / kg feed (next upper line, *) and 
3.95 ng / kg feed (upper line, +). 
 
 
 
 
Practical model identification: classical kinetic model 
In order to fit the classical kinetic model, which describes concentrations in the rest and the fat 
compartment, a relation between the concentration in the rest compartment and egg yolk has to be 
imposed. As the use of this model is to check whether the egg yolk concentrations are better approached 
with a bi-exponential model, the most obvious relation is proportionality between egg yolk 
concentration and the concentration in the rest compartment. This way a yolk development model, 
together with contaminant incorporation in yolk as outlined above, is abandoned. 
 Ignoring the initial concentrations caused by background contamination, the same fit procedure as 
in the preceding section was carried out. Again, the fits show a fair description of the data (see figure 2), 
but now also the concentrations in egg yolk at first stage of the experiment were far better represented 
by the calculated concentration-time curves. Moreover, the concentration in abdominal fat seems to be 
represented better by this model. As an objective criterion for goodness of fit, the loglikelihood is 
maximised. While the loglikelihood for the classical compartmental approach was found to be – 192, 
the likelihood of this approach was far greater: - 179. 
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Figure 2. Classical kinetic model. 
Concentration in egg yolk (left panel) and 
abdominal fat (right panel). The lines show 
the calculated concentration-time curves, 
the symbols denote experimental data. 
Five contamination levels: 0.34 ng / kg 
feed (lower line, *), 0.58 ng / kg feed (next 
lower line, +), 0.76 ng / kg feed (middle 
line, x), 1.85 ng / kg feed (next upper line, 
*) and 3.95 ng / kg feed (upper line, +). 
 
 
 
This result indicates that, while for drugs Donoghue and co-workers could develop a model for drug 
residues in egg yolk that was based on the stages of development of the yolks, a simple partitioning 
model offers a far better approach for highly lipophilic contaminants like dioxins. So, it was decided to 
abandon the submodel for incorporating contaminants proportional to the yolk growth rate and replace it 
by a model where concentration in egg yolk fat is proportional to the concentration in blood: 
 
     , , [-/day]y f y fy P V=    (17) 
 
instead of the expression in equation (11). Here, ,y fP  is the egg yolk fat:blood partition coefficient. 
 However, before proceeding this way, one more interesting result of the fit should be reported. The 
fit procedure fits, a.o., the steady state concentrations in egg yolk fat and in abdominal fat. It appears 
that the estimates for these parameters coincide within 4%, and one might well conclude that at steady 
state, the yolk egg fat concentration equals the abdominal fat concentration. There have been 
observations of egg yolk fat concentration of TEQs exceeding abdominal fat concentration. This could 
possibly have been explained, e.g., by irreversible incorporation of these kind of contaminants in egg 
yolk, i.e., using the original modelling approach. From our results one might as well assume that this 
may be more of a kinetic phenomenon. In the classical kinetic model, the concentration in egg yolk fat, 
when increasing to steady state, will exceed the concentration in abdominal fat. However, when 
decreasing from a high steady state concentration level to a low one, abdominal fat concentration will 
exceed egg yolk fat concentration. See also figure 4. The consequence of this obsevation is that the egg 
yolk fat :blood partition coefficient equals the fat:blood partition coefficient, and so 
 
     , [-/day]f y fy P V=    (18) 
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Practical model identification: classical compartmental model with partitioning between 
concentration in blood end in egg yolk fat 
The same fitting procedure as in the preceding sections was carried out. Of course, now again initial 
concentration were accounted for. This fit resulted in a still higher maximum likelihood of – 167.4, 
which is mainly due to the fact that background levels are accounted for, in contrast to the classical 
kinetic model. For the result, see figure 3. 
 
 
 
 
 
 
 
 
Figure 3. Classical compartmental model 
with partitioning instead of developing yolk 
incorporation model. Concentration in egg 
yolk (left panel) and abdominal fat (right 
panel). The lines show the calculated 
concentration-time curves, the symbols 
denote experimental data. Five 
contamination levels: 0.34 ng / kg feed 
(lower line, *), 0.58 ng / kg feed (next lower 
line, +), 0.76 ng / kg feed (middle line, x), 
1.85 ng / kg feed (next upper line, *) and 
3.95 ng / kg feed (upper line, +). 
 
 
Up to here, fits have been carried out by setting the value of the fraction absorbed to 100%. The fitted 
metabolism rate appears to be 12% of the rate of excretion by egg yolk. If instead the metabolism rate is 
set to the value 0, then the corresponding absorption fraction is fitted to be 90%, and the same value for 
the loglikelihood is obtained. Now, the value of total elimination, i.e., y k+  in the identification 
analysis section, should be the same for both fits. The sum of the rates of the fit taking 1absF =  equals 
the value 0.0514/day, while the value for the excretion rate found taking 0k =  is 0.0518 which is 
within 0.8% of 0.0514. Also, from the identification analysis one finds that the fat compartment volume 
is directly proportional to the fraction absorbed, so the volume found in the last fit should be 90% of the 
value found in the first one: it is within 0.6%. 
 The corresponding initial exponential rate is 1 0.3 (-/day)λ =  and the terminal exponential rate is 
2 0.0135 (-/day)λ = . So, the corresponding half life times are about 2.3 and 50 days. If the time to 
reach steady state is taken to be 5 terminal half life times, then after 250 days, say after 8 months, steady 
state will be reached. Note that the experimental periods of feeding contaminated food (charging) and 
clean food (discharging) are about one terminal half life time. 
 The volume of the fat compartment ranges from 265 to 295 (mL) proportional to range for the 
fraction absorbed, 90 – 100%. The corresponding weight ranges from 245 – 270 (g). Its weight was 
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estimated from experimental data and data presented in Uijttenboogaard and Germs to be about 200 (g), 
which is 22.5 – 35 % less. 
 As for the classical kinetic model, it appears hat the steady state concentrations in egg yolk fat and 
abdominal fat are almost equal. 
 In the next figure 4, the concentration-time profiles in egg yolk fat and abdominal fat for the dose 
of 1.85 ng/ kg feed are shown, together with the experimental data. Note that during the period of 
charging, the concentration in egg yolk exceeds the concentration in abdominal fat, while soon after the 
start of the period of discharging abdominal fat concentration exceeds egg yolk fat concentration. 
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Figure 4. Classical compartmental model with partitioning instead of developing yolk incorporation 
model. Concentration in egg yolk and abdominal fat. Administered dose = 1.85 ng / kg feed. The lines 
show the calculated concentration-time curves, the symbols denote experimental data: egg yolk initially 
exceeding (*), abdominal fat terminally exceeding (+). At 55 day t = individual, rather a number of 
than mixed egg yolks were sampled and analysed: note the quite large inter-individual variation. Note 
also the inter-individual variation of the abdominal fat data. Abdominal fat data in the preceding figures 
for the other dose levels were sampled from mixed individuals. 
 
The classical compartment parameters found by fitting are 
 
  
0.0784 (-/day), 0.182 (-/day), 0.18 (day)
and 1, 0.00532 (-/day), 0.0461 (-/day), 295 (mL)
or 0.9, 0.0 (-/day), 0.0518 (-/day), 267 (mL)
f r offset
abs f
abs f
q q t
F k y V
F k y V
= = =
= = = =
= = = =
 
 
Here, offsett  is the mean time of first ovulation after the start of the experiment, about 124  hours. 
 
Practical model identification: physiologically based model 
As outlined in the section on parameter identification, the parameters of the physiological based model 
can only be derived from the classical compartmental model if some additional parameter value, notably 
the blood flow through the fat compartment, is known. However, such additional information is not 
available. Though, a reasonable set of parameters could still be derived if, e.g., the fat:blood partition 
coefficient could be estimated. 
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 Suppose that the lipid content of laying hen blood, which contains about 1% of lipids (Germs), is 
composed of 50% of phospholipids and 50% of neutral lipids (like in rats). Then, based on an algorithm 
proposed by Poulin & Krishnan (1995a,b ), under neglecting of possible binding to plasma proteins, the 
partition coefficient is about 150. From this value, one may derive 
 
     3.0 3.4 (L/day)f f f fQ q P V= ≈ −   (19) 
 
In adult women, with a relative body fat content of 30% the relative adipose tissue blood flow is about 
8.5%. Laying hens, assuming a relative body fat content of about, say, 15% (= 100 × .25 (fat 
weight)/1.84 (body weight)) would correspondingly lead to a relative adipose tissue blood flow of about 
4%. So, the total blood flow would range from 75 – 85 (L/day). Given a relative volume of blood of 
about 2.7% body weight (Uijttenboogaard, 1985), i.e., about 50 mL, it follows that a laying would pump 
its total blood volume around 1 – 1.2 times per minute. This number is comparable to the same number 
for humans. 
 Given the volume of the rest compartment 1.56 (L)r fV BW V≈ − ≈ , the value for the partition 
coefficient of the rest compartment /r f r rP Q q V=  would range in an interval of about 10 - 12. 
Correspondingly, the parameter values for the excretion by egg yolk and metabolism 
 
  
0.75 - 1 (L/day)
0 - 0.1 (L/day)
r r
l r r
Y y PV
CL k PV
= ⋅ ≈
= ⋅ ≈  (20) 
 
From the other hand, the interpretation of the excretion rate in terms of egg yolk flow and laying 
efficiency is 
 
  , 0.85 150 0.006 0.765 (L/day)f y fY P Vε= = × × =  (21) 
 
Here a laying efficiency ε  of about 85% per day, i.e., 100 hens lay 85 eggs per day or one hen lays 85 
eggs during a period of 100 days, was observed. 
These estimated parameter values have been used as initial parameters when fitting the physiological 
model parameters to the data. This way, a consistent set of physiological parameters could be estimated 
(See figure 5). However, it appears that the initial estimate for the fat compartment blood flow of 3 
(L/day) was hardly changed. Equation (8) learns that the estimations of the fat:blood and rest:blood 
partition coefficients as well as the estimations of the metabolism rate and the egg yolk excretion rate 
depend linearly on the value of the fat compartment blood flow. So, taking all these parameters 10 times 
as high or as low as the parameters found by fitting, would result in the same concentration-time curves. 
This is confirmed by calculations. 
While from the one hand this is a disappointing result, from the other hand at least the mutual ratios of 
these parameters is well identified: 
 
 
1,
: : : : 3 (L/day) : 292 (mL):133 (-):11.3 (-):77 (mL/day)
0.91,
: : : : 3 (L/day) : 267 (mL):144 (-):10.9 (-):0 (mL/day)
abs
f f f r
abs
f f f r
F
Q V P P CL
F
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i.e., given an absorption fraction of 1 and the fat compartment blood flow to be 2 (L/day), the 
corresponding value for the fat:blood partition coefficient would be 2/3×133 = 88.7., etc. 
 
 
 
 
 
 
 
 
 
 
Figure 5. Physiologically based model with 
partitioning instead of developing yolk 
incorporation model. Concentration in egg 
yolk (left panel) and abdominal fat (right 
panel). The lines show the calculated 
concentration-time curves, the symbols denote 
experimental data. Five contamination levels: 
0.34 ng / kg feed (lower line, *), 0.58 pg / kg 
feed (next lower line, +), 0.76 ng / kg feed 
(middle line, x), 1.85 ng / kg feed (next upper 
line, *) and 3.95 ng / kg feed (upper line, +). 
 
 
The last figure shows the difference in the calculated concentration-time curve for the dose level of 1.85 
(ng/ kg feed). 
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Figure 6. The line which is initially and finally the lower line shows the egg yolk fat concentration 
calculated with the classical compartmental model together with incorporation proportional to yolk 
development; the line which is initially and finally the upper line shows the egg yolk fat concentration 
calculated with the classical kinetic model assuming egg yolk fat:blood partition, it is hardly discerned 
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from the two lines that cannot be discerned at all, showing the egg yolk fat concentration calculated with 
the classical compartmental model and the physiologically based model ( 3 (L/day)fQ = ) assuming 
egg yolk fat:blood partition. 
 
Discussion 
Although the different congeners administrated will show different kinetics, it was tried to model the 
total of contaminants represented by their sum of toxic equivalents (TEQs). Besides the fact that such an 
approach is less laborious, it has the practical advantage that usually the contamination with dioxin-like 
substances concerns a mix of different congeners, which is most easily represented by its TEQ value.  
 Based on the lipid solubility of the contaminants in feed and lipid uptake of laying hens from feed, 
it was estimated, partially in accordance with Pirard and De Pauw, that absorption would be fairly 
complete. This was confirmed by the estimation of the range of the fraction absorbed: 90 to 100%. 
Higher chlorinated congeners that show a reduced absorption, contribute to a small extend to the total of 
TEQs. 
 Although the data do not allow for an absolute value of the fat:blood partition coefficient, an ad hoc 
estimation for this parameter, based on lipid contents (Uijttenboogaard, 1985) and lipid composition of 
these tissues, was made (Poulin and Krishnan, 1995a,b. This estimation resulted in an estimation of 
laying hens cardiac output of about one total blood volume per minute, comparable to humans. The 
corresponding estimation of the value of partition coefficient of the rest compartment appeared to be 
about 7% of the fat:blood partition coefficient, which is consistent with data in the literature. The high 
lipophilicity of all the congeners leads to the same lipid solubility based fat:blood partition coefficient. 
The only difference with respect to partition coefficient values between congeners is their chemical 
property of binding to proteins. 
 The rate of elimination by egg yolk excretion appeared to dominate (at least a factor of 10) the rate 
of elimination by metabolism. So, differences in metabolism rate of different congeners do not 
substantially contribute to difference in their elimination. It appeared that excretion by egg yolk is likely 
to based on egg yolk fat:blood partition. This is in contrast to the findings of Donoghue and co-workers 
(Donoghue et al. 1996,1997a , 1997b, 1999, 2000, 2001). They found that for drugs as well as lindane 
egg yolk development plays a major role in their egg yolk excretion: data showed a strong correlation 
between yolk growth rate and drug incorporation in egg yolk. 
 From a number models of descending and again increasing complexity, ultimately a physiologically 
based kinetic model with two compartments was formulated to describe the kinetics of dioxin TEQs in 
laying hens. The advantage of physiologically based compartmental modelling is that it is 
mechanistically based and formulated in terms of tissue volumes, tissue blood flows, partition of 
substances between tissues and intrinsic elimination rates. Such a formulation leads to a better 
understanding of processes as absorption, distribution and elimination, as well as their interaction. Such 
an understanding cannot be obtained from the equivalent classical compartmental model, which is based 
on more abstract notions of contaminant transfer between compartments and system elimination rates. 
E.g., the rate of transfer from the fat compartment to the rest compartment is determined by fat 
compartment volume, blood flow and the fat:blood partition coefficient (see equation (8)). Nevertheless, 
the classical compartmental model as well as the classical kinetic model were very helpful for the 
identification of the physiologically based model parameters. 
 Dioxin-like contaminants are known for their persistence. This is confirmed by the kinetics of total 
TEQ in laying hens. The terminal half-life time was estimated to be about 1.7 months. Without laying, 
half life time would be about 14 months. 
